Iodothyronine 5\u27-Deiodinase: Solubilization, Partial Purification, and Characterization of a Thyroxine Deiodinase Extracted from Rat Liver Membranes by Powell, Samuel C.
Loyola University Chicago 
Loyola eCommons 
Dissertations Theses and Dissertations 
1982 
Iodothyronine 5'-Deiodinase: Solubilization, Partial Purification, 
and Characterization of a Thyroxine Deiodinase Extracted from 
Rat Liver Membranes 
Samuel C. Powell 
Loyola University Chicago 
Follow this and additional works at: https://ecommons.luc.edu/luc_diss 
 Part of the Biochemistry, Biophysics, and Structural Biology Commons 
Recommended Citation 
Powell, Samuel C., "Iodothyronine 5'-Deiodinase: Solubilization, Partial Purification, and Characterization 
of a Thyroxine Deiodinase Extracted from Rat Liver Membranes" (1982). Dissertations. 2160. 
https://ecommons.luc.edu/luc_diss/2160 
This Dissertation is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. 
It has been accepted for inclusion in Dissertations by an authorized administrator of Loyola eCommons. For more 
information, please contact ecommons@luc.edu. 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. 
Copyright © 1982 Samuel C. Powell 
I • 
IODOTHYRONINE 5 '-DE IOD INAS E 
Solubilization, Partial Purification, and Characterization of a 
Thyroxine Deiodinase Extracted From Rat Liver Membranes 
by 
Samuel C. Powell 
A Dissertation Submitted to the Faculty of the Graduate School of 
Loyola University of Chicago in Partial Fulfillment 
of the Requirements for the Degree of 
Doctor of Philosophy 
May 
1982 
The Soul enters by the throat 
-Old Turcoman saying 
ACKNOWLEDGEMENTS 
The author wishes to acknowledge the contributions of his advisor, 
Dr. Edward W. Bermes, Jr., whose patient guidance and many helpful sug-
gestions have contributed greatly towards the successful completion of 
this project. Dr. Earle Holmes is thanked for cheerfully giving of his 
time in discussing results and planning new avenues of approach. 
A considerable debt is owed to Mrs. Sonia Collins for provision of 
material help without which this work could not have been completed, and 
for her assistance in developing a radioimmunoassay procedure for triio-
dothyronine. The author wishes to thank Dr. Leonard Wartofsky and Dr. 
Keith Latham of the Kyle Metabolic Unit, Walter Reed Army Medical Center 
for their assistance in preparing separation and purification techniques 
for the iodothyronines. 
The author also wishes to thank Mr. Robert J. Kucera, Dr. Charles 
F. Lange and the faculty of the Department of Biochemistry and Biophysics 
of Loyola University of Chicago for their willingness to make available 
their technical expertise and equipment. In addition, the author would 
like to thank Dr. Stephen E. Kahn, Dr. Douglas F. Kimball, and the comr 
mittee members for their time and thought provoking suggestions. 
He also wishes to acknowledge that without the inspiration and en-
couragement of his wife Karen G. Powell and his parents Dr. and Mrs. 
Thomas E. Powell, Jr., this achievement would have been impossible. 
ii 
VITA 
The author, Samuel C. Powell was born on June 5, 1952, in Alamance 
County, North Carolina to Dr. and Mrs. Thomas E. Powell, Jr. 
Samuel received his secondary education at Walter M. Williams High 
School in Burlington, North Carolina. In August of 1970, he enrolled at 
the Virginia Military Institute in Lexington, Virginia, and received the 
Bachelor of Science degree in Chemistry in May, 1974. For the following 
two years, he studied biochemistry and clinical laboratory at Old Domin-
ion University in Norfolk, Virginia, and was awarded the degree of Master 
of Science in August of 1976. 
Upon completion of the degree requirements at Old Dom}nion Univer-
sity in May 1976, the author gained employment as a research biochemist 
with Biomedical Reference Laboratories, Inc. in Burlington, North Caro-
lina. In October, 1976, he left North Carolina for three months to at-
tend the Army Medical Department, Officer Basic Course at Fort Sam Hous-
ton in San Antonio, Texas. Returning to North Carolina in January, 1977, 
he continued at Biomedical Reference Laboratories. 
The author joined the Department of Biochemistry and Biophysics, 
Loyola University Stritch School of Medicine, Maywood, Illinois in July, 
1977. 
iii 
TABLE OF CONTENTS 
Page 
ACKNO'WLEDGEME'N'I'S ••••••••••••••••••••••••••••••••••••••••••••••••• ii 
VITA . .•.......•...............•..•..••..........•.•......•........ iii 
LIST OF TABLES ..•...........•.•.•...••.•..•.•.....•....••....•••. vii 
LIST OF FIGURES ........••••..••.......•.•..•..•....•...••.....•.. viii 
CHAPTER 
I. IN'I'RODUCI' ION • ••••..••.•••.••••••••.•..••••••••••••••••• 1 
Origin of the Thyroid Hormones •••••••••••••••.••••••. 1 
The Thyroid Hormones. 2 
Thyroxine (T4) ................................. . 2 
3,3' ,5-Triiodothyronine (T3). 5 
3,3' ,5'-Triidothyronine (rT3) 6 
Other Thyroxine Metabolites •••.•..• 12 
The Hormonal Status of Thyroxine. 12 
Peripheral Metabolism of Thyroid Hormones •••.••. 17 
Iodothyronine 5 '-Deiodinase ..•...•.•.•••.•.••.••••.•• 23 
The Present Study . ............................. ,. .... . 34 
II. MATERIALS AND METHODS ..•.••.•.••.....•••••.•••..•.•..•. 37 
Materials ........................................... . 37 
Methods . .....................................•....... 40 
Preparation of Rat Liver Homogenate ....•••.• 40 
In Vitro Studies of Thyroxine 5'-Deiodinase 
Activity ................................... . 40 
T3 Radioinnnunoassay .••.•...•.••........•....•.•. 43 
CHAPTER Page 
Subcellular Fractionation........................ 45 
Preparation of Crude Rat Liver Membranes......... 48 
Solubilization of Iodothyronine 5'-
Deiodinase....................................... 49 
Purification of Nonidet P-40 Solubilized 
Iodothyronine 5'-Deiodinase...................... 50 
Isoelectric Focusing............................. 53 
Molecular Weight Determination................... 55 
Enzymatic Assays with 125I-T4 and 125I-rT3 
Substrates....................................... 56 
III. RESULTS .•...•..............•...••..•..•..• ~············· 58 
Subcellular Fractionation............................. 58 
Solubilization of Iodothyronine 5'-Deiodinase......... 60 
Purification of Iodothyronine 5'-Deiodinase........... 62 
The Purification Procedure.... • . • • • • . . . • • . . . . . . . . 72 
Preparation of Solubilized Iodothyronine 
5 1-Deiodinase.................................... 72 
DEAE Cellulose Chromatography.................... 74 
Hydroxylapatite Chromatography................... 78 
Sepharose 6B-CL Chromatography................... 81 
Characterization of the Purified Iodothyronine 
5~-Deiodinase............ .. . . . . . . . . . . . . . . .. . .. . . . . . . . . 85 
Determination of Molecular Weight................ 85 
Isoelectric Focusing of the Nonidet P-40 
Solubilized 5'-Deiodinase. .•...•.•.••••.......... 88 
Effect of pH and Temperature. . . • . . • . • . . • • . . . . . . . . 88 
Linearity With Time and Protein 
Concentration.................................... 95 
v 
CHAPTER 
IV. 
Effect of Substrate and Detergent 
Concentration .................................. . 
Activators and Inhibitors ••••••••••••••••••• 
Determination of Kinetic Parameters and 
Possible Mechanism of Action •••••••••••••• 
Isoto~ic Studies of The Deiodination of 125r-T4 
and 1 5r-rT3 . .................................. . 
DIS CUSS ION • ••..•.........••.•..•......•.........•...... 
s L"MMA.RY ••••••• II .................................................. . 
B IBLIOGR.A.PHY . •.•••••••.•.•••••••••••••••••••••••••••••.•••••••.•• 
Vl. 
Page 
95 
102 
106 
124 
137 
156 
158 
LIST OF TABLES 
Table Page 
1. Reciprocal Relationship of Serum T3 and rT3 Concentrations 
During Non-Thyroidal Illness and in the Newborn.............. 22 
2. Distribution of Iodothyronine 5'-Deiodinase Activity 
Following Subcellular Fractionation of Rat Liver 
Homogenate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56 
3. Preparation of Nonidet P-40 Solubilized Iodothyronine 5'-
Deiodinase.................................................. 75 
4. Purification of Iodothyronine 5'-Deiodinase From 70 Grams 
of Rat Liver................................................ 84 
5. Effect of Various Agents on Fraction III T4 5'-Deiodinase 
Act i vi t y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . • . . • . . . . . . . . . . . . . . . 10 5 
6. Summary of Results (Figures 31 and 32) For The Deiodination 
of 125I-rT3 and 12Sr-T4 by Fraction D and Eraction III...... 136 
V1l 
LIST OF FIGURES 
Figure Page 
1. Molecular Structure and Numbering System for Thyroxine (T4). 3 
2. Iodothyronines Containing 3 Iodine Atoms per Molecule....... 7 
3. Relative Significance of Thyroidal and Extrathyroidal 
Sources of T3, T4 and Re1Terse T3 (rT3)...................... 9 
4. Structural Formula for Iodothyronines Containing 2 Iodine 
Atoms or Less per Molecule.................................. 13 
5. Schematic Diagram for the Stepwise Deiodination of Thyroxine 
in Peripheral Tissues....................................... 19 
6. Effect of Nonidet P-40 Concentration on the Solubilization 
of Protein from Rat Liver Membranes......................... 63 
7. Effect of Nonidet P-40 Concentration of the Solubilization 
of Iodothyronine 5'-Deiodinase Activity from Rat Liver 
Membranes •......•.......••....... :.......................... 65 
. . 
8. Flow Diagram for the Solubilization and Purification of 
Iodothyronine 5'-Deiodinase From Rat Liver Homogenates...... 73 
9. DEAE Cellulose Column Chromatography of Fraction D.......... 76 
10. Hydroxyl~patite Column Chromatography of Fraction I......... 79 
11. Sepharose 6B-CL Column Chromatography of Fraction II........ 82 
12. Estimation of Apparent Molecular Weight for Iodothyronine 
5'-Deiodinase by Gel Filtration Chromatography on Sephacryl 
S-.300 sf in the Presence of 0.1 % Nonidet P-40....... .• . .• . . 86 
13. Isoelectric Focusing cf Iodothyronine 5'-Deiodinase in the 
Presence of 0.1 % Nonidet P-40........... ... ................ 89 
14. Effect of pH and Temperature on Iodothyronie 5'-Deiodinase 
Activity.................................................... 91 
15. Thermal Inactivation of Iodothyronine 5'-Deiodinase at 56°C. 93 
16. Linearity of Iodothyronine 5'-Deiodinase Activity with Time 
and Protein Concentration................................... 96 
Vl.l.l. 
Figure Page 
17. Substrate Saturation of Iodothyronine 5'-Deiodinase 
Activity in the Presence and Absence of Nonidet P-40........ 98 
18. Effect of Nonidet P-40 and Deoxycholate on Iodothyronine 
5'-Deiodinase Activity...................................... 100 
19. Effect of Various Sulfhydryl Reagents on Iodothyronine 5'-
Deiodinase Activity......................................... 103 
20. Comparison of the Effect of Various Inhibitors and Related 
Compounds of Iodothyronine 5'-Deiodinase Activity........... 107 
21. Apparent Non-competitive Inhibition by rT3 with Respect to T4 
and Apparent Non-competitive Inhibition by rT3 with Respect 
to Dithiothreitol of T4 to T3 Conversion by the Fraction III 
5 '-Deiodinase. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109 
22. Apparent Uncompetitive Inhibition by Propylthiouracil with 
Respect to T4 and Apparent Competitive Inhibition by 
Propylthiouracil with Respect to Dithiothreitol of T4 to T3 
Conversion by the Fraction III 5'-Deiodinase................ 111 
23. Apparent Competitive Inhibition by Iodipamide (Cholografin) 
With Respect to B~th T4 and Dithiothreitol of T4 to T3 
Conversion by the Fraction III 5'-Deiodinase •...•..•.•.•.• :. 113 
24. Apparent Competitive Inhibition by Sodium Salicylate with 
Respect to Both T4 and Dithiothreitol of T4 to T3 
Conversion by the Fraction III 5'-Deiodinase................ 115 
25. Apparent Competiti7e Inhibition by Propranolol with Respect 
to Both T4 and Dithiothreitol of T4 to T3 Conversion by the 
Fraction III 5'-Deiodinase.................................. 117 
26. Lineweaver-Burk Plot of Data for the Production of T3 from 
T4 by the Fraction III 5'-Deiodinase at Different 
Concentrations of Dithiothreitol (DTT)...................... 120 
27. Det~rmination of Km and Vmax Values from Replots of Kinetic 
Data ..................................... ~................... 122 
28. Demonstration of Parallel Linea for the Lineweaver-Burk 
Plot When ~inetic Data for the Conversion of T4 to T3 Was 
Generated in the Presence of a Competitive Inhibitor of T4.. 125 
29. Linearity of Iodothyronine 5'-Deiodinase Activity with 
Increasing T4 Concentrations at a Constant Molar Ratio of 
T4 to Dithiothreitol........................................ 127 
Figure Page 
30. Effect of Time and pH on the Deiodination of 125I-rT3 by 
Fraction D................................................. 129 
31. Comparison of Iodothyronine 5'-Deiodinase Activity in 
Fraction III, Fraction D, and a Mixture of Fraction D 
Plus Fraction III for the Diodination of 125I-rT3.......... 132 
32. Comparison of Iodothyronine 5'-Deiodinase Activity in 
Fraction III, Fraction D, and a Mixture of Fraction D 
llus Fraction III for the Conversion of 125I-T4 to 
25r-T3 ......................... "............. ... . . . . . . . . . . . 134 
X 
CHAPTER I 
INTRODUCTION 
Origin of The Thyroid Hormones 
The thyroid gland, an endocrine gland lying across the trachea 
lateroinferior to the thyroid cartilage, is the source and primary regul-
ator of serum thyroxine (T4) concentrations (Taurog, 1978). In addition 
to thyroxine, its major hormone product, the thyroid gland also produces 
small amounts of two other iodinated thyronine molecules: triiodothy-
ronine (T3) and reverse triiodothyronine (rT3) (Chopra!!~·, 1978). 
The production of these hormones by the follicular cells of the thyroid 
gland occurs in four steps: 1) elemental iodine is concentrated, 2) 
tyrosine residues in the protein thyroglobulin are iodinated, 3) iodi-
nated tyrosines in thyroglobulin are coupl~d to form iodothyronine, and 
4) the hormone product is released from thyroglobulin by enzymatic hydro-
lysis (Freiden and Lipner, 1972). Every animal species found in nature 
has specific cells or tissues capable of the first two steps, trapping 
and storing elemental iodine in an organic form (Gorbman, 1978). How-
ever, the ability to regulate the formation of iodinated thyronine resi-
dues from the oxidative coupling of two iodinated thyronine residues, and 
the ability to regulate the subsequent enzymatic hydrolysis of the iodi-
nated thyronine residues are biochemical phenomena found only in members 
of the vertebrate animal kingdom (Gorbman, 1978). Indeed, all adult mem-
bers of vertebrate species studied thus far have follicular thyroid cells 
capable of producing the iodinated thyronines (Henderson and Gorbman, 
1971). l 
2 
In addition to the thyroid gland, other extrathyroidal tissues, 
primarily the liver and kidney have been shown to contribute to the serum 
concentrations of T3 (Braverman~~., 1970) and reverse T3 (Chopra, 
1976). These peripheral tissues contain specific deiodinases which pro-
duce T3 and rT3 as a result of the monodeiodination of T4 (Visser~~., 
1976a). It has been reported that as much as 80% of the circulating 
serum T3 and as much as 97 % of the circulating reverse T3 may be derived 
from the degradation of T4 in the peripheral tissues (Chopra~~., 
1975a; Schimmel and Utiger, 1977). The continued stepwise deiodination 
of thyroxine in the peripheral tissues also results in the production of 
diiodinated and monoiodinated thyronines (Chopra et at., 197Sa; Small-
ridge~~., 1979; Pangaro !£~·' 1980). 
The Thyroid Hormones 
Thyroxine (T4) 
Thyroxine was discovered by Edward Kendall on Christmas Day, 1914, 
when the first purified crystals of thyroxine (T4) were obtained from an 
alkaline hydrolysate of bovine thyroid glands (Kendall, 1929). The pro-
duct he obtained was biologically active and gave a cherry red color when 
reacted with nitrous acid (Kendall and Osterberger, 1919). Kendall pro-
posed that the substance was an iodinated derivative of tryptophan and he 
orignally named the compound thyroxindole. Harrington and Barger identi-
fied the correct structure (Figure 1) in 1927, and changed the name of 
the compound to thyroxine (Harrington and Barger, 1927). Interestingly, 
Kendall originally chose the name thyroxindole rather than the one that 
3 
Figure 1. Molecular structure and numbering system for thyroxine (T4). 
A. The molecular structure of thyroxine consists of an diiodo-
substituted phenol ring attached to a diiodotyrosine by an ether linkage. 
The oxygen bridge imposes an angle of 120° on the axis of symmetry be-
tween the 2 aromatic rings. Despite a steric hindrance by the bulky io-
dine atoms of the inner ring, molecular orbital calculations indicate 
that the energy barrier to rotation of the outer ring about its axis of 
symmetry is sufficient!~ low to allow rapid rotation at ~oom temperature 
(Kollman!!~·, 1973). The chemical formula for T4 is: C15H1104N l4· 
Thyroxine has a molecular weight of 776.88 g/mol. Of its total weight, 
1.8% is nitrogen and 65.4% is iodine. B. The adopted numbering system 
for the aromatic rings is as shown. Primed numbers are used to number 
the carbon atoms of the outer ring. The chemical name for thyroxine is: 
1~beta-3,5-diiodo-4-(3' ,5'-diiodo-4'-hydroxyphenoxy)-phenyl-alpha-amino 
proprionic acid. Thyroxine is classified in Chemical Abstracts as a de-
rivative of the amino acid alanine: alanine,-3-[4-(4-hydroxy-3,5-
diiodophenoxy)-3,5-diiodophenyl]. 
A 
I 
B 
4'- hydroxyl 
HO 
0 
3,3',5,5'- tetraiodothyronine ( T4) 
2 
I 
5' 6 
outer ring . . tnner nng 
R 
alanine 
side chain 
4 
5 
would emphasize the iodine component because he felt that it was the 
structure of the organic nucleus and not the iodine content that gave the 
hormone its physiologic activity (Kendal, 1929). This original idea has 
recently been proven to be true by demonstration of thyroid hormonal ac-
tivity in halogen-free analogs of T4 (Jorgensen, 1978). 
Trevorrow (1939) first proposed the presence of T4 in human serum 
(Trevorrow, 1939). He found that most of the iodine in plasma coprecipi-
tated with serum proteins and was extractable with organic solvents. The 
actual identification of plasma T4, however, was first accomplished nine 
years later with the successful crystallization of T4 from human serum 
(Taurog and Chaikoff, 1948). More recently, studies using radioimmuno-
assay procedures have substantiated the existence of circulating T4, and 
have indicated that it may account for up to 90 % of the total protein-
bound plasma iodide (Beckers~~., 1972; Chopra, 1978). Normal human 
serum concentrations of T4 are in the range of 4.5 to 11.5 ~g/100 mL 
(Chopra~~., 197Sa). 
3,3' ,5-Triiodothyronine (T3) 
Thyroid hormone and thyroxine (T4) became synonymous terms fol-
lowing the establishment of the structure of thyroxine in 1927, by Har-
rington and Barger. For many years, thyroxine was considered the only 
thyroid hormone, and clinicians began an effort to relate its serum con-
centrations to thyroid disease states. Then, in 1954, Gross and Pitt-
Rivers reported the existence of a second iodinated thyronine 1n normal 
human serum as well as in the thyroid gland itself (Gross and Pitt-
Rivers, 1954). This compound contained 3 iodine atoms and became known 
6 
as triiodothyronine (T3) (See Figure 2). This "new" hormone was 
effective in treating myxedema. Studies in thyroidectomized rats showed 
that T3 had a more rapid onset of action and was from 3 to 7 times more 
potent than T4 in stimulating oxygen consumption and in preventing goiter 
formation. Therefore, these workers proposed that while T4 was the major 
form in which thyroid hormone was secreted, triiodothyronine (T3) was the 
more active form within the cells of the target tissues (Gross and Pitt-
Rivers, 1954). This theory is still valid and at the present time T3 is 
considered to be the most physiologically active of the naturally occur-
ing iodothyronines (Ingbar and Braverman, 1975; Latham et ~·· 1976; 
Chopra, 19i8; Jorgenson, 1978). 
Triiodothyronine (T3), like T4 is produced by the thyroid gland, 
however, the primary source of serum T3 is the enzymatic monodeiodination 
of T4 to T3 in peripheral tissues (See Figure 3) (Braverman!!~·· 1970; 
Chopra, 1978). As a result of both thyroidal and peripheral production, 
the human serum concentration of T3 ~s normally in the range of 92 to 190 
ng/100 mL (Chopra!!~·' 1975a). The enzyme responsible for the conver-
sion of T4 to T3 removes a single iodine atom from the 5'-position in the 
phenol ring of T4 and, therefore, is described as an iodothyronine 5'-
deiodinase. The biologic significance of the conversion of T4 to T3 is 
considered to be that of an activating pathway whereby T4 functions as a 
prohormone. 
3,3' ,5 1 -Triiodothyronine (rT3) 
The enzymatic conversion of T4 to T3 in peripheral tissues leading 
to increased plasma T3 concentrations is now well established. In addi-
7 
Figure 2. Iodothyronines containing 3 iodine atoms per molecule. 
The molecular configuration is shown for triiodothyronine (T3) and 
reverse T3 (rT3). The outer ring of T3 has a single iodine substituant. 
In comparison, the inner ring of rT3 has a single iodine substituant. By 
convention, the lower number is llsed in the descriptive term, and a 3 
instead of a 5 is used to indicate the position of iodine in the outer 
ring of T3 and in the inner ring of rT3. 
8 
3,3',5- triiodothyronine (T 3) 
3,3,5'- triiodothyronine (rT3) 
9 
Figure 3. Relative significance of thyroidal and extrathyroidal sources 
of T3, T4 and reverse T3 (rT3). 
An approximation of the amount of hormone excreted daily by the 
thyroid gland, and the amount of hormone derived from the peripheral 
deiodination of T4 each day is diagrammed based on data from previous 
publications (Schimmel and Utiger, 1977; Chopra et al., 1978). Of the 
approximate 90 ~g of T4 produced each day by the~hyroid gland, approxi-
mately 30 ~g (33 %) is converted to T3, a slightly greater amount, 43 ~ 
(48 %) is converted to rT3, and the remaining 17 ~g (19 %) is metabolized 
by processes other than deiodination. (Figure based on diagram presented 
by Schimmel and Utiger, 1977.) 
/ 
T3 
iodothyronine 
D 5
1
-deiodinase 
< 
T3 
36 ~g/day 
~ 6~g 
0 3o~g 
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"" rT3 
~ produced in thyroid 
D produced in peripheral 
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~ 
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....... 
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tion, the peripheral tissues also convert a nearly equal amount of T4 to 
a second triiodothyronine commonly referred to as reverse T3 (Figure 3). 
Reverse T3 (rT3) (Figure 2), is found in normal serum in a concentration 
range of 27 to 62 ng/100 mL (Chopra~.!!.·, 1975a; Vagenakis ~ .!.!_., 
1975). It is currently proposed that a specific monodeiodinase, "iodo-
thyronine 5-deiodinase" is responsible for the conversion at T4 to rT3 
(Cavalieri~.!.!_., 1977; Chopra~.!.!_., 1978; Sakurada ~ .!.!_., 1978; 
Kaplan and Utiger, 1978; Gavin~.!.!_., 1980). In contrast to T3, rT3 is 
calorigenically inactive (Stasilli ~ .!.!_., 1959; Gavin et .!!_., 1977; 
Chopra, 1978) and the conversion of T4 to rT3 is regarded as an inactiv-
ating pathway for T4 metabolism. The iodothyronine 5-deiodinase is 
responsible for the production of most, if not all, of the circulating 
serum rT3 (Schimmel and Utiger, 1977; Gavin~.!.!_., 1977). 
In addition to being calorigenically inactive, rT3 has also been 
shown to have a negative effect on the calorigenic activity of both T4 
and T3 (Pittman and Barker, 1959, Pittman~.!!_., 1960) and has actually 
been used to treat hyperthyroidism (Benua ~.!!_., 1959). Reverse T3, 
however, may not be antagonistic to T4 and T3 in all of its effects. For 
example, at pharmacologic doses, the effect of rT3 is as potent or more 
potent than T3 in the inhibition of phosphodiesterase activity in rat 
calvaria (Marcus et ~., 1975), and in stimulating erythropoiesis in 
mouse bone marrow cells (Golde~.!!_., 1976). At normal concentrations, 
however, rT3 appears to be more antagonistic than additive to the overall 
thyroid effect (Chopra, 1978) and, therefore, is generally considered to 
be a negative effector of thyroid hormone activity. 
12 
Other Thyroxine Metabolites 
The thyroxine metabolites containing less than 3 iodine atoms per 
molecule (See Figure 4) are considered to be of only minor physiological 
importance. These compounds have biological half-lives of less than one 
hour, and normal human serum concentrations are in the range of from 0.8 
to 17 ng/dL (Chopra~.!!.·, 1972; Burman!:!_.!!.·, 1977; Smallridge~.!!_., 
1979; Meinhold and 3churnbrand, 1978; Pangaro ~.!!.·' 1980). These par-
tially iodinated thyronines are thought to be the result of continued ex-
posure of T3 and rT3 along with their metabolites to the peripheral deio-
dinase enzymes. For example, it has been shown that thyroidectomized 
rats will metabolize radiolabelled T3 or rT3 in v~vo to 3,3'-T2 (Roche et 
.!!.·, 1956; Flock~.!!,., 1960). The in vitro conversion of T3 and rT3 to 
3,3'-T2 in rat liver homogenates has also been demonstrated (Chopra, 
1976). These deiodinases are not to be confused with those normally 
present in the thyroid and concerned with iodide conservation. All of 
the partially iodinated thyronines shown in Figure 4 have been detected 
in normal human serum using radioimmunoassay procedures suggesting, 
therefore, that thyroxine can be completely deiodinated in the peripheral 
tissues. The iodine released during peripheral deiodination is conserved 
by the body (Surks and Oppenheimer, !969). 
The Hormonal Status of Thyroxine 
The physiological importance of T4 as an intrinsically active thy-
roid hormone has recently been questioned (Braverman~.!!.·, 1970; 
Schwartz~.!!.·, 1971; Oppenheimer~.!!.·, 1972). Increasing evidence 
indicates that in the euthyroid state most, if not all, of the metabolic 
I 
HoOoOcH2 -CH(NH2> cooH 
I 
3,5-diiodothyronine (3,5-T2) 
I I 
Ho0'o0' CH -CH(NH )COOH 
- - 2 2 
3,3'- d ii odothyronine (3,31-T2) 
I HoO'~CH -CH(NH )COOH 
- v\_J_ 2 2 
I 
3:5·- d i i o d othyronine { 3•,5•-T2) 
I 
HoQo0cH2-cH(NH2>cooH 
3 -monoiodothyronine ( 3-T I) 
I 
HoQoQcH2 -CH(NH2>cooH 
31-monoiodothyronine (3•-TI) 
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Figure 4. Structural formula for iodothyronines containing 2 iodine 
atoms or less per molecule. 
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effect of the thyroid hormones can be attributed to T3. During certain 
disease states, when the serum ratio of T3 to T4 is decreased, the 
contribution of T4 to the metabolic effect may increase, However, in the 
normal healthy adult the contribution of T4 to the overall ~etabolic 
effect of the thyroid hormones is estimated to be 15 % or less, and T4 is 
thought to serve the body primarily as a reservoir of prohormone for T3 
(Ingbar and Braverman, 1975; Chopra, 1978). 
One way in which the relative contributions of T4 and T3 to the 
biologic effect of the thyroid hormones has been estimated is on the 
basis of daily turnover rates and the relative potency of T3 and T4. 
Data now available indicate that the calorigenic activity of T3 is from 2 
to 4 times greater than that of T4, and that from 1/3 to 1/2 of the T4 
metabolized each day is converted to T3 in the peripheral tissues (Brown 
~~·, 1974; Braverman~ al., 1970). Based on this data, Brown and 
colleagues estimated that 65 % of the physiological effect of the thyroid 
hormones produced each day is due to T3 while 35 % is due to T4 (Brown et 
~., 1974). This estimate was later modified to reflect the fact that 
rT3, which has less than 5 % of the calorigenic activity of T4 (Pittman 
~~·, 1962; Stasilli ~ ~·, 1959), is also a major product of the 
peripheral metabolism of T4. Taking into account the metabolism of T4 to 
rT3, the estimated contribution of T4 to the biologic effect of thyroid 
hormones was reduced from 35% to about 14% (Chopra, 1978). In addi-
tion, it was pointed out that the original estimate was based on a daily 
turnover rate of 110 ~g T4/day. If the more commonly observed value of 
90 ug T4/day is used, the final estimate of the activity attributable 
directly to intact T4 would decrease nearly to zero (Chopra, 1978). 
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A second approach to determining the relative contribution of T4 
and T3 to the metabolic effect of the thyroid hormones has been esti-
mating the cross-reactivity of T4 with T3 at nuclear binding sites. This 
approach is based on the assumption that the binding of hormone to 
nuclear binding proteins (NBP) is responsible for the initiation of hor-
monal action, and that the contribution of T4 and T3 to total hormonal 
activity depends on the mass of T4 and T3 bound to the NBP sites (Oppen-
heimer and Surks, 1975; Mariash and Oppenheimer, 1980). Perhaps the best 
estimates of the binding capacities of nuclear sites have been generated 
under in vivo conditions (Latham!!~·· 1976). Binding studies by 
Oppenheimer and colleagues utilized in vivo isotopic studies to determine 
binding capacities pf T3 and T4 to rat hepatocytes (Oppenheimer~~., 
1974). Their results indicated that T4 binds to the same NBP sites as 
T3, but with an association constant approximately 1/20 that of T3. The 
actual content of T3 and T4 bound specifically to the rat liver NBP was 
calculated to be 20.3 x lo-13 and 2.83 x lo-13 mol/g liver tissue respec-
tively (Oppenheimer~~., 1974). This data predicts that the biologi-
cal effect of T3 exceeds the intrinsic contribution of T4 by a factor of 
about 7, or that approximately 12 %of the total met~bolic activity of 
the thyroid hormones is due to T4 (Oppenheimer and Surks, 1975). Similar 
results were predicted for the relative potency of the thyroid hormones 
~n man (Oppenheimer~~., 1974). 
In another set of in vivo experiments propylthiouracil (PTU), a 
potent inhibitor of the iod~thyronine 5'-deiodinase, was given to hypo-
thyroid patients receiving supplemental thyroxine. The administration of 
PTU did not cause a significant change in serum T4 levels, however, it 
did result in decreased serum T3 levels and a modest increase in serum 
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thyroid-stimulating hormone (TSH) levels (Geffner~~., 1975). Propyl-
thiouracil has also been shown to be associated with anti-T4 effects in 
the rat (Oppenheimer~!!·' 1972). Results from the studies with PTU 
were interpreted to indicate that T3 may be the sole biologically active 
thyroid hormone (Oppenheimer~~., 1972; Chopra, 1978). 
Two theories have been proposed to explain why T3 has a greater 
biological potency than T4. The first theory suggests that the iodine in 
the 5'-position of T4 creates steric hindrance to binding of T4 at re-
ceptor sites (Oppenheimer and Surks, 1975). Binding to the functional 
receptor would be more difficult for T4, therefore, than for TJ, which 
has only one iodine atom in the phenolic ring. The second theory is 
based on the fact that at physiological pH, the 4'-hydroxyl group of T4 
is dissociated while the 4'-hydroxyl group. of T3 is not (Latham ~!!·• 
1976). The presence of a single iodine in the phenol ring of T3 peturbs 
the pKa (-log of the dissociation constant) of the 4'-hydroxyl group from 
10.1 as in tyrosine to 8.40, and the second iodine in the phenol ring of 
T4 ~eturbs the pKa of the 4'-hydroxyl group to approximately 6.46 (Smith, 
1970). It is suggested, therefore, that the presence of a 4'-hydroxyl 
group at physiological pH gives T3 a greater binding affinity than T4 for 
the functional receptor proteins of the target cell (Latham et ~·, 
1976). This theory has been supported by the demonstration that T3 binds 
optimally to rat liver NBP at pH 7.6 and that T4 binds optimally to rat 
liver NBP at pH 6.0 (Latham~ !!·• 1976; Eberhardt~~., 1979). It 
has also been shown that above pH 8.2, the binding affinity of T3 for rat 
liver NBP decreases to a point equal to or less than the binding affinity 
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of T4 (Latham !E._..!!..·, 1976). 
Peripheral Metabolism of Thyroid Hormones 
!odothyronines undergo transformations in the peripheral tissues by 
three major routes: conjugation, deiodination, and degradation. Conju-
gation occurs in hepatic tissues and results in the formation of sulfate 
ester and glucuronide conjugates which are excreted in the bile (Bhaga-
van, 1974; White !E..!!..·• 1978). There is normally a high tubular respor-
tion capacity for free T3 and T4, and very little if any thyroid hormone 
is excreted in the urine (Adlkofer !E..!!..·, 1980). Deiodination occurs by 
a specific set of enzymes which act in a stepwise manner to strip iodine 
from either the inner or outer ring of the iodothyronines. These enzymes 
are located in the liver and kidney as well as many other peripheral 
tissues (Chopra, 1977a). Degradation occurs by several enzymatic path-
ways: An hepatic aminotransferase is active in the deamination of both 
iodotyrosines and iodothyronines and results in the formation of pyruvic 
analogs of the thyroid hormones (White !E..!!..·, 1978). The formation of 
acetic acid analogs occurs in the kidneys by a two-step process which 
includes an initial deamination and a subsequent decarboxylation step 
(Braverman et ~., 1970). The liver catalyzes an a-methylation of the 
acetic acid analogs utilizing S-adenosylmethionine (SAM), and the liver 
and kidney both catalyze the rupture of the diphenyl ether bridge, the 
ortho hydroxylation of the phenol rings, and the degradation of the ala-
nine side chain (White !E..!!..·, 1978). The three major routes are not 
mutually exclusive and pyruvic acid and acetic analogues of T4, T3 and 
rT3 are found in normal human serum (Chopra~ ..!!..·• 1978). 
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Deiodination is the primary step in the catabolic pathway for 
thyroxine. It is estimated that of the total amount of T4 removed from 
the plasma pool each day, 70 % to 80 % undergoes peripheral deiodination, 
another 15 % to 20 % is conjugated and excreted in the bile, and the re-
maining 5 % to 10 % is deaminated or decarboxylated (Bhagavan, 1974; 
Ingbar and Braverman, 1975; White~~., 1978). 
The deiodination of T4 in the peripheral tissues is of uppermost 
biological importance. In addition to being the major catabolic route of 
thyroxine metabolism, the bidirectional deiodination of T4 (See Figure 3) 
is responsible for the production of approximately 80 % of the plasma T3 
and 93 % or more of the plasma rT3 (Chopra, 1976; Schimmel and Utiger, 
1977). The continued stepwise deiodination of T4 ~s also responsible for 
the presence of most if not all of the piasma mono- and diiodinated thy- · 
ronines (Rudolph~~., 1976; Chopra~~., 1978; Sorimachi and 
Cahnmann, 1979). A schematic diagram of the stepwise deiodination scheme 
for thyroxine showing the possible steps and partially iodinated interme-
diates is shown in Figure 5. The individual steps in the deiodination 
sequence are presently thought to be catalyzed by enzymes which have a 
high affinity and specificity for the iodothyronine substrates. 
It is proposed that the enzymes active in the conversion of T4 to 
T3 (5'-deiodinase) and of T4 to rT3 (5-deiodinase) are components of two 
distinct enzyme systems. Experiments have shown that the inner and outer 
ring deiodinases have different pH optimum (Cavaleri ~~·, 1977; Kaplan 
and Utiger, 1978; Sorimachi and Robbins, 1979), and that the 5'-
deiodinase and the 5-deiodinase have maximal activity in the particulate 
and soluble fractions of cellular homogenates respectively (Cavalieri et 
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Figure 5. Schematic diagram for the stepwise deiodination of thyroxine 
in peripheral tissues. 
The solid arrows indicate those steps catalyzed by an outer ring 
monodeiodinase (5'-deiodinase). The outlined arrows indicate those steps 
catalyzed by an inner ring monodeiodinase (5-deiodinase). 
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~·~ 1977; Chopra, 1977a). Perhaps the most convincing evidence of two 
distinct enzyme systems is a reciprocal relationship that exists between 
T3 and rT3 concentrations in normal cord umbilical serum and in serum 
from patients suffering from a variety of nonthyroidal illnesses (Table 
1). These conditions are characterized by normal or near normal levels 
of serum T4, decreased levels of serum T3 and a corresponding increase in 
serum rT3. Were there only a single enzyme catalyzing the conversion of 
T4 to T3 and T4 to rT3, one would expect the serum levels of T3 and rT3 
to increase or decrease in parallel. 
The bidirectional conversion of T4 to T3 and rT3 offers a mechanism 
whereby T4 can act as a prohormone and be activated by conversion to T3 
or be deactivat~d by conversion to rT3. Therefore, an analogy to vitamin 
D3 metabolism has been proposed for the metabolism of T4. For example, 
tn the metabolism scheme for vitamin D, 25-hydroxy-cholcalciferol is con-
verted by a double enzyme system in the kidney to either the biologically 
active 1,25-dihydroxy form or to the inactive 24,25-dihydroxy form of 
'litamin D (DeLuca~~·, 1973). When 1,25-(0H) 2 -D3 production is 
decreased, there is a corresponding increase in the production of 24,25-
(0H)2-o3 and vice versa (Tanaka and DeLuca, 1974). The peripheral deio-
dination of T4 to T3 and rT3 1s quite similar in that it is also thought 
to be controlled by a double enzyme system consisting of the S-and 5'-
deiodi~ase enzymes, and as indicated in Table 1, a decrease in the levels 
of T3 are associated with a corresponding increase 1n serum rT3 levels in 
a variety of "sick euthyroid" conditions. 
The mechanism by which the body controls the bidirectional deiodin-
ase system to result in decreased serum T3 levels is presently unknown. 
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Table 1 
Reciprical Relationship of Serum T3 and rT3 Concentrations 
During Non-Thyroidal Illness and in the Newborn 
Study TOTAL* FREE* 
Group T4 T3 rT3 T4 T3 rT3 
Newborn 
t 
' 
t t 
' 
t Cord serum 
Hepatic t 
"' 
t t J t Cirrhosis 
Chronic t ·t t t t t Renal Failure 
Acute 
t l t t t Febile Illness 
Protein 
t 
' 
It Calorie 
Malnutrition 
*Increased and decreased values for total and free (dialyzable) hormone 
levels are based on serum concentrations for each study group as reported 
by Chopra and colleagues (Chopra et al., 1975a). The size of the arrows 
are roughly proportional to relative-rncreases or decreases in serum hor-
mone concentration. 
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It has been proposed that a decrease in the concentration of the active 
5'-deiodinase, or reductions in intracellular cofactor (reduced gluta-
thione, NADPH) concentrations during starvation, stress and febrile ill-
ness might be responsible for the reduced iodothyronine 5'-deiodinase 
activity (Balsam and Ingbar, 1979; Harris~~., 1979). In addition, it 
has been suggested that glucocorticoids, which have an inhibitory effect 
on the conversion of T4 to T3, may also be involved with the reduction in 
5'-deiodinase activity (Chopra~~., 1975a; Westgren ~~., 1977). 
Increases in serum rT3, on the other hand, result from decreased degrad-
ation rates as well as increased production, and inhibition of the 5'-
deiodinase that metabolizes rT3 to 3,3'-T2 is thought to be a major con-
tributor to increased serum rT3 levels (Kaplan and Utiger, 1978; Lumholtz 
~~., 1979). 
Within the past 10 years, the importance of iodothyronine 5'-
deiodinase in regulating serum levels of T3 and, therefore, in potenti-
ating the biologic effect of thyroxine has been recognized. As a result 
of increased interest in the extrathyroida1 metabolism of thyroxine, a 
major effort is currently being made by numerous groups to elucidate the 
biochemical properties of the 5 '-deil,dinase and to determine what factors 
affect the catalytic rate of T4 to T3 conversion. 
Iodothyronine 5'-Deiodinase 
The possibility that T3 might be derived from the conversion of T4 
to T3 in the peripheral tissues in addition to direct thyroidal secretion 
was first proposed by Pitt-Rivers and colleagues in 1955 (Pitt-Rivers et 
~., 1955), and the first evidence of the in vitro, extrathyroida1 con-
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version of T4 to T3 was reported by Albright and Larsen (1959). Interest 
in the deiodinase system was slow to develop, however, because it had not 
been conclusively demonstrated in vivo that T4 was converted to T3 in 
peripheral tissues (Lassiter and Stanbury, 1958). Therefore, the ques-
tion lay dormant until 1970, when Braverman, Ingbar and Sterling demon-
strated the conversion of T4 to T3 in athyroidic patients maintained on 
highly purified T4 (Braverman~~., 1970). At first the peripheral 
conversion was proposed to be a nonenzymatic random deiodination (Surks 
and Oppenheimer, 1971). This proposal was widely accepted because T4 was 
deiodinated to T3 and rT3 in approximately equal amounts, and because in 
vitro assays in crude homogenate systems failed to show substrate satura-
tion (H~fner and Kh~pfle, 1976). In 1975, Vagenakis and colleagues de-
monstrated that rT3 increased corresponding to a decrease in T3 in serum 
from fasting patients (Vagenakis ~~., 1975), and interest turned once 
again to an enzymatic mechanism. Fisher and Sack proposed that the re-
action was catalyzed by tyrosine hydroxylase (Fisher and Sack, 1975). 
This proposal was subsequently discounted on the basis that alpha-
methyl-para-tyrosine, a specific inhibitor of tyrosine hydroxylase, did 
not affect the in vitro deiodination of T4 (H~fner, ~~., 1977). 
Finally, in 1977, Chopra demonstrated in vitro substrate saturation by 
T4, and demonstrated that the deiodinase activity was enzymatic in nature 
(Chopra, 1977a). Since 1977, the 5'-deiodinase has been studied in a 
variety of animal systems both in vivo and in vitro. 
Iodothyronine 5'-deiodinase activity has been observed in all ver-
tebrate species studied. In mammalian species, the enzyme is present in 
the highest concentrations in the kidney, liver, and pituitary tissues 
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(Chopra, 1977a; Cheron !!!l·' 1980). Muscle, heart, spleen, brain, in-
testine, and thyroid tissues contain smaller amounts of activity (Chopra, 
1977a; Ishii~~., 1981). Polymorphonuclear leukocytes (Woeber and 
Maddux, 1978), lymphocytes (Kvethy, 1978), and fibroblasts (Refetoff et 
~., 1972) also have been shown to have 5'-deiodinase activity. 
Within the cell, 5'-deiodinase activity appears to be distributed 
throughout the cellular membranes with the microsomal and plasma membrane 
fractions being particularly rich in enzyme activity. After conventional 
subcellular fractionation (de Duve !! !l·, 1955), the largest single 
fraction of T4 to T3 converting activity is the crude microsomal fraction 
(Visser!! !l·, 1976b; Takaishi _!! !l·, 1979). This fraction, however, 
contains no more that 50 % of the total cellular activity, and results 
from more elaborate fractionation studies have shown that of the activity 
in the crude microsomal and nuclear fractions, a major portion of the 5'-
deiodinase co-purifies with enzyme markers associated with the plasma 
membrane fraction (Maciel !! !l·, 1979). 
Iodothyronine 5'-deiodinase activity has been studied in vitro 1n 
numerous laboratories using crude membrane preparations or whole cell 
homogenates of various tissues. There has been no report of a successful 
solubilization of an active form of the enzyme, and all studies have been 
performed on particulat~ preparations of the 5'-deiodinase. The most 
purified particulate preparations thus far achieved have been microsomal 
membrane preparations which have allowed increases in specific activity 
of from 2-to 6-fold in comparison to the crude homogenate preparations 
(Visser_!! !l·, 1976b; Hoffken _!! .!!_., 1978; auf dem Brinke!! !l·, 
1979). 
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Iodothyronine 5'-deiodinase activity has been shown to be sensitive 
to both temperature and pH. The temperature optimum has been reported to 
be 37 °C (Chopra, 1977a). Preincubation of enzyme preparations for 60 
minutes at 24 °C, 37 °C, and 56 °C resulted in the loss of 15 %, 43 %, 
and 98 %, respectively of the recoverable activity (Chiraseveenprapund et 
~., 1978). Optimum pH values at 37 °C have been reported in the range 
of 6.0 to 7.35 (Hgffken !!~·' 1977; H~fner !!~·' 1977; Chopra, 
1977a). 
Iodothyronine 5'-deiodinase activity has been reported to be linear 
with time (37 °C) during the initial 45 to 60 minutes of incubation 
(Chiraseveenuprapund !!~·' 1978; Sorima~hi and Robbins, 1979). Linear-
Lty with protein concentration, however, has not been observed for the 
crude enzyme preparations (Leonard and Rosenberg, 1977; Sorimachi and 
Robbins, 1979). 
The current literature has been inconsistent concern~ng the effects 
of various ions on the activity of the 5'-deiodinase, however, it has 
been generally agreed that there are no requirements for metal cofactors 
(Kaplan and Utiger, 1978) and that the ions: 
K+ do not have a major inhibitory or stimulatory effect (Visser!!~·' 
1976b; Chopra, 1976; Sorimachi and Robbins, 1979). Heavy metal ions 
including: zinc, mercury, lead, and silver, on the other hand, have been 
shown to be potent dose-dependent inhibitors of the 5'-deiodinase (Cho-
pra, 1977b). 
It has recenlty been observed that several sulfhydryl agents inclu-
ding dithiothreitol (DTT), mercaptoethanol, cysteine, and reduced gluta-
thione are potent stimulators of iodothyronine 5'-deiodinase activity 
27 
(Chopra, 1977b; Harris~~., 1979). On the other hand, oxidized gluta-
thione has befon shown to inhibit monodeiodination (Chopra~~., 1978). 
In addition, the sulfhydryl oxidizing agent, diamide, and the sulfhydryl-
binding agent N-ethylmaleimide have also been shown to be potent inhibi-
tors of the 5'-deiodinase (Chopra~~., 1978). Based on these data and 
the demonstration of thiol dependent activity in microsomal preparations, 
it has been proposed that the presence of thiol-containing compounds is 
essential for 5'-deiodinase activity (Chopra~~·, 1978; Sorimachi and 
Robbins, 1979; Leonard and Rosenberg, 1980b). The naturally occuring, 
endogenous cofactor has been proposed to be reduced glutathione (Visser 
~~., 1976b; Chopra~~., 1978; Harris~~., 1979). NADPH has been 
proposed to have an activating e;fect in vivo as a reductant for regener-
atin~ reduced glutathione (Balsam and Ingbar, ·1978; Chopra~~·, 1978). 
No other chemical activators or dialyzable cofactors of the 5'-deiodinase 
have been reported. 
The stimulation of T4 to T3 conversion by the presence of thiol 
group-containing compounds has been proposed to result in part from their 
efficiency in maintaining the 5'-deiodinase in its active conformation 
(Chopra~~·, 1978). It is suggested, therefore, that the enzyme may 
exist in an inactive conformation characterized by disulfide linkages 
between cysteine residues, and that in the active conformation these 
disulfide bonds are reduced. In addition, it has been proposed that the 
thiol group-containing compounds may act as cofactors and participate 
directly in the reductive deiodination of T4 (Chopra~~., 1978; Vis-
ser, 1979). 
In addition to sulfhydryl-binding and sulfhydryl-oxidizing agents, 
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the 5'-deiodinase is inhibited in a dose-dependent manner by various T4 
metabolites including: rT3, 3' ,5'-T2, and 3,3'-T2 as well as by propyl-
thiouracil, sodium salicylate, and some iodinated x-ray contrast agents 
(Visser~.!.!_., 1978; Chopra~.!.!_., 1978; Chopra~.!.!_., 1980). Pro-
pranolol, a beta-adrenergic blocking agent, has also been reported to 
have an inhibitory effect on the in vitro conversion of T4 to T3 (Lum-
holtz ~ .!.!_., 1979; van Noordan ~ .!.!_., 1979). Reverse T3, the most 
potent inhibitor of the various agents studied so far, has been reported 
to be both a competitive inhibitor with K1 's of 0.045 ~mol/L (Chopra, 
1977a) and 0.0045 ~mol/L (Kaplan and Utiger, 1978), and to be a non-
competitive inhibitor (K1 a 0.02 ~mol/L (H~fner, 1977). Propylthiouracil 
has been reported to be an uncompetitive inhibitor with respect to T4 
concentration, a competitive inhibitor with respect to dithiothreitol 
concentration (Visser ~ .!.!_., 1978), and an allosteric effector (Kaplan 
and Utiger, 1978). Sodium salicylate and the iodinated x-ray contrast 
agents have been reported to be competitive inhibitors (Chopra~.!.!.·, 
1978; Chopra~.!.!.·, 1980). The conversion of T4 to T3 is reported not 
to be affected by dexamethasone (Kaplan and Utiger, 1978); by T3 (H~fner 
~~., 1977); by 3,5-T2, iodotyrosines; nor by methylated, brominated, 
or chlorinated analogs of rT3 (Chopra~~·· t978). 
Iodothyronine 5 '-deiodinases catalyze the .:;onversion of rT3 to 
3,3'-T2 as well as the conversion of T4 to T3 (See Figure 5). The simi-
larities in these 2 steps has led to an ongoing debate over whether the 
same enzyme catalyzes both reactions. Several findings suggest that both 
steps are carried out by the same enzyme. First, the tissue distribution 
and subcellular location of both 5'-deiodinases is similar (Chopra~ 
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~., 1978). Secondly, both activities require the presence of thiol-
group-containing compounds for activity and both are inhibited by propyl-
thiouracil in an uncompetitive manner (Chopra~~., 1978). Thirdly, 
rT3 is an inhibitor of T4 to T3 conversion and T4 is an inhibitor of the 
rT3 to 3,3'-T2 deiodinase (Visser~~., 1979b). In addition, both 
activities have been shown to decrease during· fasting and hypothyroidism, 
and to increase in response to hyperthyroidism (Kaplan and Utiger, 1978). 
There are, however, several findings that do not support a one enzyme 
theory. For example, the Km of rT3 for the 5'-deiodinase (65 nmol/L rT3) 
is approximately 40-fold lower than the Km of T4 (3.0 ~mol/L T4), and the 
optimum pH for the T4 to T3 and rT3 to 3,3'-T2 activities are 6.5 and 
8.0, respectively (Visser~~., 1979b). Moreover, while the character-
istically low serum T3 and T4 to 13 converting activity in tissues of the 
fetus increase to normal adult levels within a few hours of birth, the 
characteristically high serum rT3 levels in the fetus do not decrease to 
adult levels until the second week of postnatal life (Maciel~~., 
1979). If the outer ring deiodinases for T4 and rT3 were identical, one 
would expect the changes to be more nearly synchronized. Thus, while the 
two activities are similar in some respects, the question of similarity 
versus identity awaits purification of the 5'-deiodinase. 
Kinetic studies utilizing crude membrane preparations have been 
performed by several groups to determine the Michaelis-Menten constant 
(Km) and the velocity for the conversion of T4 to T3. The apparent Km 
for the 5'-deiodinase of these crude preparations has been reported to be 
in a range of from 0.8 to 7.7 ~mol/L T4 (H~fner ~~., 1977; Chopra, 
1977a; Kaplan and Utiger, 1978; auf dem Brinke !!~·, 1979), and the 
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velocities of the most purified membrane preparations have been reported 
typically to be in a range of from 0.5 to 1.2 pmol T3 min-lmg-1 (Takaishi 
et al., 1979; Leonard and Rosenberg, l980b). 
--
Iodothyronine 5'-deiodinase is thought to catalyze the reductive 
deiodination of T4 (Visser~~., l976b). It is proposed that a 
T4 + 2 R-SH --+ T3 + HI + R-SS -R 
thio1-group-containing compound (R-SH) acts as a second substrate and 
that the products of the reaction are T3, HI and the oxidized thiol. It 
is also proposed that the conversion of rT3 to 3,3'-T2 occurs by the same 
mechanism (Visser et ~·, l979b). 
When the kinetics of the outer ring deiodination of rT3 to 3,3'-T2 
were examined using different concentratio!J,S of DTT over a range of rT3 
concentrations, the concentration of DTT added to the enzyme assay mix-
ture was found to affect both the Km and maximum velocity such that a 
family of parallel lines was generated when a double reciprical plot of 
velocity vers,~s rT3 concentration was plotted at differing concentrations 
of dithiothreitol (Visser, 1979). This type of kinetic data is charac-
teristic of a two-step or ping-pong mechanism in which the enzyme oscil-
lates between two stable forms (Cleland, 1963). Visser and colleagues 
suggested that the conversion of rT3 to 3,3'-T2 might occur by a ping-
pong mechanism where (E-SH) represents the active form oi the 
rT3 2 R-SH 
E-SH 
\L3'-T2, 
E-S I 
\/SS~R 
E-SH + HI 
[rT3•ESH] 
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enzyme and (E-5I) represents a stable intermediate sulphenyl iodide (RS-
I) form of the enzyme (Visser~~., 1979b). According to this type of 
mechanism, the deiodination reaction occurs in two steps. The first step 
was proposed to involve a concerted mechanism whereby a primary attack of 
the rT3 substrate by an enzyme sulfhydryl group resulted in a enzyme-
hormone complex (rT3•E-SH) which subsequently broke apart releasing free 
3,3'-T2 from the iodinated enzyme (E-SI) (Visser~~., 1979b). In the 
second step, the oxidation of two thiol equivalents reduced the enzyme 
back to its original active form and allowed the release of free hydrogen 
iodide (HI). 
The proposed ping-pong mechanism has been supported by the demon-
stration that propylthiouracil (PTU) inhibits the 5'-deiodinase uncompe-
titively with respect to rT3 and competitively with respect to dithio-
threitol (Visser, 1979). It has been demonstrated that the reaction of 
iodine with protein yields sulphenyl iodides which are highly reactive 
towards thiouracil derivatives (Cunningham, 1964). Competition between 
PTU and dithiothreitol for the sulphenyl could, therefore, explain the 
competitive inhibition with respect to dithiothreitol. By binding to the 
sulphenyl, PTU would effectively lower the concentration of active enzyme 
available for the deiodination of rT3, and t~is could explain the appa-
rent uncompetitive inhibition with respect to rT3. These results are 
consistent with the formation of a sulphenyl iodide enzyme intermediate. 
The T4 5'-deiodinase is also inhibited in a competitive manner by 
PTU with respect to T4 (Chopra, 1977a). Therefore, it has been proposed 
that the deiodination of T4 to T3 also occurs by a ping-pong mechanism 
(Visser~~·· 1979b). Other reports, however, have suggested that the 
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Km of the T4 5'-deiodinase is not affected by the concentration of dithi-
othreitol (Chopra, 1977b). If this is true, it would indicate that the 
conversion of T4 to T3 does not occur by the ping-pong mechanism. 
Due to the particulate nature of the iodothyronine 5'-deiodinase, 
purification of the enzyme requires membrane extraction. Preliminary 
studies have shown that solubilization of the 5'-deiodinase from rat 
liver microsomal preparations requires detergent concentrations suffi-
cient to result in extensive membrane dissassembly (Takaishi et al., 
--' 
1979). Therefore, instead of being adsorbed to the membrane surface (ex-
trinsic protein) or being included within luminal cavities of microsomal 
vesicles (matrix protein), the iodothyronine 5'-deiodinase was found to 
be an integral component (instrinsic protein) of rat liver microsomal 
membranes. 
Previous attempts to solubilize the 5'-deiodinase from rat liver 
and kidney membranes (Takaishi !!~·' 1979; Leonard and Rosenberg, 
1980a, 1980b) and from beef liver membranes (Tseng and Ltham, 1981) de-
monstrated that deoxycholate was effective in solubilizing approximately 
60 % of the deiodinase from cellular membranes, however, the enzyme was 
inactive in the presence of even small amounts of the detergent (Leonard 
and Rosenberg, 1980) and removal of deoxycholate by QAE-Sephadex chroma-
tography, dialysis or adsorption techniques was required to demonstrate 
activity in solubilized fractions. After detergent removal, the 5'-
deiodinase could be stored for 3 days at 4 °C, or for 1 month 3t -70 oc 
with little or no loss in activity (Leonard and Rosenberg, 1980b). The 
extracted enzyme was poorly soluble in aqueous buffers, however, and the 
removal of detergent resulted in the formation of macromolecular aggre-
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gates of the enzyme. These aggregates were excluded from Sepharose 6B-CL 
when gel filtration was performed in the absence of detergent, and they 
were shown, by isopycnic banding to have a membrane-like density of ap-
proximately 1.17 g/mL (Leonard and Rosenberg, 1980a). 
The membrane-like density is suggestive of the presence of phospho-
lipid and, in fact, the presence of phospholipid has been demonstrated to 
be essential for catalytic activity. Phospholipase A2 treatment of the 
solubilized enzyme resulted in a concentration and time dependent loss of 
T4 to T3 converting activity, and the addition of soybean phospholipid 
prevented the lipase inactivation in a competitive manner (Leonard and 
Rosenberg, !980a). 
Gel filtration of the solubilized iodothyronine 5'-deiodinase in 
the presence of deoxycholate allowed elution of T4 to T3 converting acti-
vity after the void volume. The molecular weight of the deoxycholate 
solubilized 5'-deiodinase from rat kidney membranes was estimated by 
Sepharose 6B-CL chromatography in the presence of Na deoxycholate to be 
approximately 85,000 (Leonard and Rosenberg, 1980a). A 5'-deiodinase 
enzyme complex solubilized from beef liver membranes has been reported to 
have 2 included components when chromatography was performed on agarose 
0.5 M ln the presence of Na deoxycholate. The apparent molecular weights 
of the 2 components were estimated to be 95,000 and 200,000 (Tseng and 
Latham, 1981). 
Attempts to purify the solubilized iodothyronine 5'-deiodinase in 
the presence of deoxycholate have resulted in extremely low yields of ac-
tive enzyme. Gel filtration chromatography, for example, resulted 1n 
yields of less than 10% (Leonard and Rosenberg, 1980b). The poor re-
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covery of activity was found to be due in part to delipidation during gel 
filtration as evidenced by a 5-fold increase in percent yield following 
the addition of membrane lipid extracts (Leonard and Rosenberg, 1980b). 
In addition to attempts to purify the 5'-deiodinase by gel filtration 
chromatography, the mention of a preliminary attempt to purify the 5'-
deiodinase by adsorption chromatography on QAE-Sephadex and by fraction-
ation with ammonium sulfate has been reported in abstract form (Tseng and 
Latham, 1981). To date, no other purification attempts have been pub-
lished and no successful purification of the 5'-deiodinase has been 
reported. 
The Present Study 
A large body of evidence in the literature supports the existence 
of a specific membrane-bound iodothyronine 5'-deiodinase that catalyzes 
the conversion of T4 to T3. There is also substantial evidence to sug-
gest that T3 is several times more biologically active than T4. There-
fore, the 5'-deiodinase has recently been the subject of intense investi-
gation due to its potential role in the pathogenesis and treatment of 
thyroid disease. The present study was undertaken in the interest of 
illuminating the physical and enzymatic characteristics of the iodothyro-
nine 5'-deiodinase. 
At the present time, very little information is available regarding 
the physical properties of the 5'-deiodinase, and there is considerable 
disagreement among the various investigations of the enzyme's catalytic 
activity. This is due, in part, to the fact that the enzyme has only 
been studied in crude preparations of whole cell homogenates and micro-
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somal membranes. I now report a technique for the membrane extraction of 
iodoth~ronine 5'-deiodinase, and the development of a multistep purifica-
tion procedure. The purification procedure was used to prepare purified 
thyroxine 5'-deiodinase from rat liver membranes for use in the investi-
gation of physical properties and kinetic characteristics. 
Physical characterization studies included the estimation of appar-
ent molecular weight and the determination of isoelectric point for the 
rat liver iodothyronine 5'-deiodinase. 
Catalytic characterization studies involved the determination of 
optimum conditions for enzymatic activity, the determination of Km and 
VMax' and a study of inhibition by several known inhibitors including re-
verse T3, propylthiouracil, iodipamide, sodium salicylate, and proprano-
· lol. 
A p~ng-pong mechanism has been proposed for the 5'-deiodination of 
rT3 to 3,3'-T2 (Visser!!~., 1979b). In the present study, kinetic as-
says utilizing the purified rat liver 5'-deiodinase were performed for 
the conversion of T4 to T3 to determine if the deiodination of T4 might 
also occur by a ping-pong type mechanism. 
Similarities in the subcellular location and catalytic effectors of 
the 5'-deiodinase that converts rT3 to 3,3'-T2 and the 5'-deiodinase that 
converts T4 to T3 have led to the hypothesis that the same enzyme cata-
lyzes both reactions (Chopra!!~·, 1978; Visser!!~·' 1979b). There 
are, however, several findings that do not support a one enzyme theory 
such as differences in pH optimum, substrate binding constants and the 
in vivo metabolism of T4 and rT3 in the neonate (Maciel et al., 1979). 
--- --
In the present study, kinetic assays were performed with the purified 
iodothyronine 5'-deiodinase to determine if the T4 to T3 con~erting 
enzyme also carried out the monodeiodination of rT3 to 3,3'-T2. 
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CHAPTER II 
MATERIALS AND METHODS 
Materials 
Rat liver tissue was obtained from male and female, Sprague-Dawley 
laboratory rats maintained on Purina rat chow and tap water ad libitum. 
Groups of from 2 to 10 rats weighing 100-250 g each were anesthetized 
with chloroform and exsanguinated by cutting the portal vein and hepatic 
artery. The liver was removed, sliced into small fragments, rinsed in 
cold saline (0 °C) and placed into 10 mL vials. Liver tissue prepared 1n 
this manner could be stored 6 months or longer at -60 °C with no effect 
on the specific activity of the iodothyronine 5'-deiodinase. The non-
radioactive substrate !:,-thyroxine (T4), was obtained from Sigma Chemical 
Co., St. Louis, MO. as the highly purified free acid, and was used with-
out further purification. Other substrates, 125r-labeled T4 purchased 
from Nuclin Diagnostics, Northbrook, IL., and 125r-labeled reverse T3 
(rT3) from AmershamrSearle, Arlington Heights, IL. were purified by 
Sephadex G-25 chromatography (Green, 1972) prior to use. The reduced 
thiol-group-containing cofactors: 1-cysteine, glutathione, 2-mercapto-
ethanol, DL-dithiothreitol and DL-6,8-thioctic acid amide (lipoamide) 
== = 
were obtained from Sigma. The inhibitors and related compounds: methi-
mazole, demamethasone, Q1-propranolol, sodium diatrizoate (Hypaque) and 
6-~-propyl-2-thiouracil (PTU) were purchased from Sigma. Sodium salicy-
late was obtained from Matheson, Coleman and Bell, Norwood, OH., and io-
dipamide (Cholografin) was purchased from Squibb and Sons, Princeton, NJ. 
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Diethylamineothyl (DEAE) Cellulose (medium mesh), Concanavalin A 
(Con A) Sepharose 4B, Sepharose 4B, 6B-CL, Sephacryl S-300 superfine 
(sf), Sephadex G-25 medium and Sephadex G-25 superfine were obtained from 
Sigma. Carboxymethyl (CM) cellulose (CM 22) was a product of Whatman, 
Clifton, NJ. The sulfhydryl affinity resin, Affi-gel 401 and the hydro-
xylapatite resin were purchased from Bio•Rad, Richmond, CA. The organo-
mercurial Sepharose 4B resin was synthesized according to the procedure 
of Sluyterman and Wijdeness (1974). 
Buffers used throughout the purification of the rat liver iodothy-
ronine 5'-deiodinase included: homogenate buffer (A) 5 mmol Tris-HCL, 
250 mmol sucrose, pH 8.0; homogenate buffer (B) 25 mmol KP04, 50 mmol 
NaCl, 1 mmol EDTA, 0.02% NaN3, 10 ~ol 2-mercaptoethanol (BME), pH 6.5; 
extraction buffer (C) 2 mmol KP04, 10 mmol NaCl, 1 mmol EDTA, 0.02% NaN3, 
10 mmal BME, pH 7.5; column buffer (D) 2 mmol KP04, 10 mmol NaCl, 1 mmol 
EDTA, 0.02% NaN3, 10 mmol BME, 0.1 % Nonidet P-40, pH 7.6; elution 
buffer (E) same as buffer D except for the content of NaCl which was 
increased to 500 mmol NaCl; column buffer (F) Same as buffer D except pH 
6.5; elution buffer (G) 500 mmol KP04, 150 mmol NaCl, l mmol EDTA, 0.02 ~ M 
NaN3, 10 mmol BME, 0.1 % Nonidet P-40, pH 6.5; gel filtration column 
buffer (H) 25 mmol KP04, 50 mmol NaCl, 1 mmol EDTA, 0.02 % NaN3, 10 mmol 
BME, 0.1 % Nonidet P-40, pH 6.5. 
The detergents, Triton X-100 and deoxycholate, and pancreatic lip-
ase were purchased from Sigma. Nonidet P-40 was obtained from Bethesda 
Research Laboratories, Rockville, Md. A test kit containing the zwitter-
ionic detergents, derivatives of N-hexadecyl-N,N-dimethyl-3-amino-1-
propane sulfonates, were obtained from Calbiochem Behring Corp., La 
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Jolla, CA. 
All reagents used for the quantitation of T3 by radioimmunoassy 
were of the highest purity commercially available. Rabbit antisera to T3 
was obtained from Endocrine Science Laboratories, Tarzana, CA. Calbio-
che~Behring was the source of goat antibody to rabbit gamma globulin 
{GARGG). Non-radioactive 3,3' ,5-triiodo-1-thyronine (T3) was supplied by 
Sigma. 125r-labeled T3 with a specific activity of approximately 2400 
~Ci/~g was purchased from Nuclin Diagnostics. Reagent alcohol (95% 
ethanol) was the product of Mallinkrodt, St. Louis, MO. Human serum 
pools were kindly provided by the clinical laboratory of Loyola Univer-
sity Medical Center, Maywood, IL. Activated charcoal "Norit A" was pur-
chased from Matheson, Coleman and·Bell. 
Other reagents: bovine serum albumin (Cohn fraction V powder), 
Coomassie Brilliant Blue G-250, and 3,5'-diiodo-1-thyronine (3,5-T2) were 
purchased from Sigma. Carrier ampholytes (3/10) were the product of LKB 
Instruments, Inc., Rockville, MD. Purified proteins used for the cali-
bration of gel filtration columns were obtained from Pharmacia, Piscata-
way, NJ. 
The following specialized equipment was utilized: A Potter-
Elvehjem tissue homogenizer (55 mL flask, Kontes Glass Co., Vineland, 
NJ.) with the stan-dard teflon pestle (0.007 inch clearance) and a pestle 
that was turned on a lathe to a clearance of 0.024 inches (Fleischer and 
Kervina, 1974). Dounce homogenizer (40 mL flask; Kontes Glass Co.) with 
standard large clearance (A) and small clearance (B) pestles; miracloth 
filtration material (Calbiochem); Sorvall Superspeed (RC2-B) refrigerated 
centrifuge with the SS-34 rotor (rmin = 5.72 em, rmax = 10.80 em); 
Beckman preparatory L5-65 ultracentrifuge with the SW-27 head (rmin = 
7.53 em, rmax = 16.12cm); Beckman "Microfuge" (Model 152) with 400 lJL 
disposable microtubes (Walter Sarstedt, Inc., Princeton, NJ); Amicon 
Corp., Chicago, IL) washed according to the procedure of Brewer (1974), 
and stored prior to use at 4 °C in deionized water with 0.02 % NaN3 
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as a· bacteriostatic agent; LKB electrofocusing column (110 mL Ampholine 
column, #8100); LKB gradient mixer (Model 8121); D.C. power supply 
(Buchler Instruments, Fort Lee, NJ); and a TI-59 programmable calculator 
with Master Library Module software program (Texas Instruments, Inc., 
Dallas, TX). 
Methods 
Preparation of Rat Liver Homogenates 
Homogenates of the rat liver tissue were prepared with a motor 
driven Potter-Elvehjem homogenizer. The frozen tissue was thawed in 4 
volumes of homogenate buffer A or homogenate buffer B and all subsequent 
steps were carried out·at 0-4 °C. The initial tissue disruption was per-
formed with 3 passes of pestle A and cellular homogenization was com-
pleted with 3 to 5 passes of pestle B. The resulting 20 % homogenate was 
filtered through a single layer of miracloth to remove unbroken cells and 
tissue fragments. The filtrate (Fraction A), containing approximately 28 
mg protein/mL was st~red in 10 mL aliquots at -60 oC or used directly as 
the source of the iodothyronine 5'-deiodinase for purification studies 
and for subcellular fractionation studies. 
In Vitro Studies of Thyroxine 5'-Deiodinase Activity 
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T4 to T3 converting activity was measured by a modification of 
methods described previously (Chopra, 1977a; Maciel~~., 1979; auf dem 
Brinke ~~·· 1979). In summary, aliquots of samples suspected of con-
taining thyroxine 5'-deiodinase activity were incubated with non-radio-
active T4 for the time periods given in RESULTS, and the amount of T3 
generated was measured by radioimmunoassay (RIA) performed on a ethanol 
extract of the incubation mixture. Under standard reaction conditions, 
the following reagents were added in 12 x 75 mm polystyrene culture tubes 
in the order given: 1) 320 ~L of 150 mmol/L phosphate buffer containing 
1 mmol/L EDTA, pH 6.5; 2) 50 ~L of 200 mmol/L dithiothreitol, made fresh 
in the same buffer; 3) 100 ~L of enzyme preparation; 4) 30 ~L of sub-
strate solution containing 250 ~g T4/mL deionized water. The final 500 
~L volume containing 20 mmol/L dithiothreitol, 19.3 ~ol/L T4, and 0.01-
0.5 mg protein buffered to pH 6.5 was mixed gently by swirling and placed 
in a water bath thermostated to 37 °C. The reaction was stopped following 
a 30 min incubation (standard reaction conditions) by extraction of the 
incubation mixture with 2 volumes (1.0 mL) of 95 % ethanol. This concen-
tration of ethanol destroyed enzymatic activity completely and afforded a 
96-100 % recovery of iodothyronines. The assay tubes were then tightly 
capped, mixed by inversion to facilitate complete extraction of the T3, 
and the precipitated protein was pel1eted by centrifugation for 10 min 
(1,000 x £)· Each assay contained zero incubation tubes (blanks) which 
were handled exactly as described above except that the 100 ~L aliquot of 
sample was added following incubation and immediately prior to the ex-
traction step. The T3 content of the blank tubes was considered to re-
present T3 formed from the spontaneous deiodination of T4, T3 contained 
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in the commercial T4 preparation, and "apparent" T3 resulting from the 
cross-reactivity of T4 in the T3 radioimmunoassay. The blank varied from 
4.5 to 7.2 ng T3/tube when 7.5 Ug T4 was used in the assay. This value 
was subtracted from T3 measured in the test samples to determine the 
amount of T3 produced from the enzymatic deiodination of T4. The results 
were expressed in units of activity which were defined as the quantity of 
enzyme that transformed 1 pmol T3 per min at 37 °C. 
To study the effect of various conditions on 5'-deiodinase activ-
ity, changes in standard assay procedure were made as indicated in the 
text and Figure legends. The addition of various agents to the enzyme 
assay incubation mixture were made by replacing aliquots of enzyme assay 
buffer with equal volumes of solutions containing the test agents. When 
the effects of various salts wera studied, the phosphate buffer was made 
up without EDTA. When studying the effect of various cofactors, solu-
tions of the various sulfhydryl agents were used in place of the dithio-
threitol solution. 
Kinetic studies on crude and purified preparations of the 5'-
deiodinase were pe~formed using standard assay conditions with varying 
substrate or cofactor concentrations. Data were generated under condi-
tions of initial reaction rates and plotted by the method of Lineweaver 
and Burk (1934). For the determination of apparent Km and Vmax were 
determined from replots of the primary data (Dixon and Webb, 1979a). 
Kr's for the various inhibitors were determined from a replot of apparent 
Km or Vmax values determined in the presence of fixed inhibitor concen-
trations (Lineweaver and Burk, 1934; Dixon and Webb, 1979d). 
Enzyme assays performed on samples from the subcellular fraction-
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ation study were carried out in the absence of detergent. Unless indica-
cated otherwise, all other assays were done on samples containing 0.1 % 
Nonidet P-40. Sample volumes of 100 ~L were diluted to a final 500 ~L in 
the reaction mixture resulting in a final 0.02 % detergent concentration. 
This concentration was slightly above the critical micellular concentra-
tion (CMC) of 0.017% for Nonidet P-40 (Helenius and Simons, 1975). For 
samples not containing 0.1% Nonidet P-40, detergent was added or samples 
were diluted in homogenate buffer B. 
Due to the nonlinearity of activity with high protein concentra-
tion, serial dilutions of the crude fractions (A through E) were assayed 
for 5'-deiodinase activity in order to relate their activity to that of 
the more purified fractions. Maximum protein concentrations used were 
less"than 5 mg/mL. Fraction III and other fractions of high specific 
activity were diluted in buffer H to protein concentrations no lower than 
0.10 mg/mL. All enzyme specific activities were based on protein deter-
minations by Coomassie Blue dye-binding (Bradford, 1976) using bovine 
serum albumin as the standard. 
T3 Radiommunoassay 
3,3' ,5'-Triiodo-1-thyronine (T3) quantitation was performed by a 
double antibody radioimmunoassay technique very similar to that described 
previously for the quantitation of T4 (Collins~~-, 1980). Reaction 
mixtures were pipetted into 400 ~L disposable microtubes in the following 
order: 1) 120 ~L of sample (20 ~L of enzyme extract + 100 ~1 charcoal 
stripped serum); 2) 100 ~L T3 Trace (125I-T3 sufficient to generate 
approximately 24,000 cpm/0.1 mL prepared in 100 mmol/L barbital buffer, 
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pH 8.6 containing 0.5% bovine serum albumin, 0.5% thimerosal and 0.6 mL 
of rabbit serum per 100 mL); 3) 100 ~L T3 Antibody (lyophilized rabbit T3 
antiserum reconstituted in the same buffer as used for dilution of T3 
Trace with the exception of deletion of rabbit serum; optimal dilution 
should allow binding of 45-55 % of the 125t-T3 in the absence of non-
radioactive T3); 4) 25 ~L Precipitating Antibody (goat anti-rabbit gamma-
globulin (GARGG) antibody reconstituted according to manufacturers reco~ 
mendation). Following the addition of GARGG, the contents of the assay 
tubes were mixed and allowed to incubate for 16 h at room temperature. 
The tubes were then centrifuged for 2 min (10,000 x £) in a Beckman 
microcentrifuge to precipitate the bound hormone complex, and the unbound 
hormone was removed by aspiration. The cpm of 125t-T3 remaining in the 
precipitant were determined. by counting each tube in an automatic gamma 
counter for a period of 60 sec. T3 Standards (0,25,50,75,100,150,200,-
300,500 and 600 ngT3/100 mL) were made up in charcoal stripped serum and 
were run with each assay by replacing the 100 ~L of charcoal stripped 
serum in step (1) with 100 ~L of the respective T3 Standard. In a like-
wise manner, control pools were assayed to determine inter-and intra-
assay variation. A total counts tube, consisting of 100 ~L T3 Trace, and 
a nonspecific binding (NSB) tube, set up as described above using bar-
bital buffer in the place of T3 Antibody for the zero T3 standard, were 
also added to each assay. Data for the standard curve were linearized in 
the form of a logit-log plot (Rodbard !!~·' 1968) with the use of a TI-
59 programmable calculator. The NSB (<S %) and the precision (inter-
assay and intra-assay coefficients of variation <8 %) compared favorably 
to that reported previously (Collins!!~·, i980). 
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Extracts of the enzyme assay containing 63.3 % ethanol were added 
to the RIA incubation mixture in 20 ~L aliquots. This volume resulted in 
a final 3.7% concentration of ethanol and resulted in an increase in the 
slope of the standard curve of from -2.6 to -2.4. In order to minimize 
the effects of ethanol on measurements of T3 by the RIA procedure, 20 ~L 
aliquots of the incubation mixture were consistently used through-out 
this study, and 20 ~L aliquots of 63 % reagent alcohol were added to 
standard and control tubes as described. Since the ethanol extract con-
tained little or no protein, as evidenced by a lack of precipitant in the 
presence of 10 % trichloroacetic acid, use of 63 % reagent alcohol alone 
to treat the standards and controls was considered sufficient to. render 
the unknowns comparable to the standards (Chopra, 1977a). The presence 
of Nonidet P-40 in the ethanol extract (0.0067 %) resulted in a final 
detergent concentration of 0.0004 % ~n the RIA mixture, and was found not 
to have a significant effect on the performance of the radioimmunoassay. 
Any effects of other non-T3 substances on the RIA were taken into account 
by measuring T3 in the zero-incubation (blank) tubes. 
The sensitivity of the assay varied from 15 to 25 pg T3 per tube, 
as determined by the amount of T3 required to reduce the number of cpm of 
the zero standard by 10 %. This allowed detection of as little as 1.35 
ng T3 ~n the enzyme assay incubation mixture. This amount was a very 
small fraction (0.02 %) of the 7.5 ~g T4 added per enzyme assay. 
Subcellular Fractionation 
Subcellular fractions of the rat liver homogenate (Fraction A) were 
prepared by the method of Aronson and Touster (1974), with slight modifi-
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cation. Fraction A, suspended in homogenate buffer A, was centrifuged at 
1,000 x £for 10 min. The supernatant was removed by pipette and the 
pellet was rehomogenized in buffer A. This step was repeated twice and 
the three supernatants were combined and designated as the cytoplasmic 
extract (Fraction E). The washed pellet, resuspended in 57% sucrose, 
was labeled as the nuclear fraction. In order to sediment the nuclei, 
the nuclear fraction was centrifuged at 33,000 x £for 7.5 min. Follow-
ing centrifugation, the supernatant fluid was removed by aspiration and 
the fluffy, dark brown material layered over a small firm pellet of tan 
material was decanted. This dark brown material was suspended in 3 
volumes of 57% sucrose and labeled as Fraction N (nuclei). The super-
natant and the tan pellet were discarded. The cytoplasmic extract (Frac-
tion E) was also centrifuged at 33,000 x £for 7.5 min to obtain the 
mitochondrial and lysosomal pellet (Fraction M + L). The remaining 
33,000 x £ supernate was centrifuged at 78,000 x £ for 100 min. The 
resulting pellet, resuspended in 4 volumes of 57 % sucrose, was labeled 
as Fraction P (microsomal fraction). The 78,000 x £supernatant was 
labeled as Fraction H (cell cytosol). 
Plasma membrane fractions were obtained from the nuclei (Fraction 
N) and microsomal (Fraction P) preparations by high speed centrifugation 
in a discontinous sucrose gradient according to the procedure of Avonson 
and Touster, 1974. In short, 15-18 mL of the suspended crude nuclei (N) 
or i3-15 mL of the crude microsomes (P) were placed in the bottom of cel-
lulose nitrate centrifuge tubes for the Beckman SW-27 rotor. Fifteen 
milliliters of 37.2 % sucrose were then carefully layered over the nuclei 
sample without mixing of the layers, and a third layer of 250 mmol/L 
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sucrose was added in the same manner for a total volume of 38.5 mL. On 
the microsomal fraction were layered 17 mL of 34 % sucrose and a layer of 
250 mmol/L sucrose to a final volume of 38.5 mL. The discontinuous gra-
dients were then centrifuged at 75,500 x £ (24,000 rpm) for 16 h. The 
electronic brake was used to decelerate the rotor at the end of the run. 
Fractions from each run were collected. Four fractions were obtained 
from the nuclei: The first, a layer of congealed fat (Nl), floated at 
the top of the gradient. A plasma membrane band (N2) consisting of small 
pieces of a tan material appeared at the interface of the 250 mmol/L and 
37.2 % sucrose layers. The 37.2 % layer was removed as the third frac-
tion. This band (N3) was reported to consist of mitochondria and seg-
ments of plasma membrane. The bottom portion containing the nuclei was 
the final fraction (N4). Four fractions were also obtained from the 
microsomal material: The first, a layer of congealed fat (Pl) floated at 
the top of the gradient. The plasma membrane fraction (P2), a thick band 
of white material, formed at the interface between the 250 mmol/L and 34 
% sucrose layers. The 34 % sucrose layer (P3) appeared faintly cloudy 
and contained a mixture of plasma membranes and microsomes. The micro-
somal membrane fraction (P4) appeared at the top of the 57 % sucrose sam-
ple layer. 
All resuspensions, following centrifugation steps, were done with 
the aid of a Dounce type tissue homogenizer. Homogenization was accom-
plished with from 2 to 4 complete strokes of the "A" pestle through the 
homogenate suspensions. All steps were carried out at 0-4 °C. Buffer 
flasks were pre-chilled on crushed 1ce. The homogenate solutions were 
kept on ice at all times except during centrifugation steps which were 
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carried out in refrigerated centrifuges. All sucrose solutions were made 
in 5 mmol/L Tris buffer and titrated to pH 8.0 (23 •c) with 1 mol/L HCL 
prior to their final dilution. Buffers were checked for sucrose concen-
trations by refractometry. The percent sucrose, as read directly from a 
Seitz refractometer at 25 •c, was determined to be ± 0.05 % of the con-
centrations given. The complete separation procedure required approxi-
mately 48 hours from start to finish and aliquots saved from each frac-
tion were dialyzed against a 10-fold dilution of buffer B prior to pro-
tein quantitation and enzyme activity studies. All enzyme assays were 
run concurrently to determine the relative specific activity of thyroxine 
5'-deiodinase in each fraction. 
Preparation of Crude Rat Liver Membranes 
Fraction A homogenate prepared in buffer B and stored frozen in 10 
ml aliquots for up to 6 months at -60 oC was thawed rapidly in a 37 °C 
water bath with continual agitation. Just prior to complete thawing, the 
vials were placed in ice water. The thawed homogenate was then centri-
fuged at 37,000 x ~ for 1 h in a Sorvall SS-34 rotor. The cytosol (Frac-
tion B) was decanted and saved for further analysis. The firm light 
brown membrane pellet and a clear yellow gel at the bottom of the centri-
fuge tube were resuspended in homogenate buffer B to initial volume and 
centrifuged a second time at 37,000 x ~for 1 h. Following the second 
centrifugation, the clear supernate was discarded and the crude membrane 
pellet was resuspended ~n initial volume in extraction buffer C and 
labeled as Fraction C. 
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solubilization of Iodothyronine 5'-Deiodinase 
Several extraction techniques were attempted 1n preliminary studies 
to achieve a selective solubilization of the rat liver iodothyronine 5'-
deiodinase from Fraction C. These techniques were performed according to 
commonly used membrane extraction procedures (Morton, 1955; Penefsky and 
Tzagoloff, 1971) and included: acid and alkali extraction, freezing and 
thawing, extraction with organic solvents (~-butanol and ethanol), enzy-
matic digestion with pancreatic lipase, and detergent solubilization with 
deoxycholate, zwittergents (sulfobetaines), Triton X-100, and Nonidet P-
40. A description of the conditions utilized is given in the text and 
figure legends of the Results section. The method chosen in the present 
study for solubilization of the membrane bound 5'-deiodinase was solubil-
ization with Nonidet P-40. All steps w~re carried out at 0-4 °C. 
Commercially prepared Nonidet P-40 (NP-40) was used without further 
purification and a 10 % working solution was prepared by diluting the 
commercial reagent with deionized water. This solution could be kept for 
several weeks at room temperature without the formation of a precipi-
tate. 
Solubilization of T4 S'-deiodinase activity was carried out in two 
steps. In the first step, NP-40 was added to Fraction C in a dropwise 
manner with stirring to a final concentration of 0.05 %. The detergent-
membrane mixture was stirred for an additional 10 min, and homogenized 1n 
the Dounce homogenizer with 10 complete strokes of pestle A, and 2 
strokes with pestle B. The suspension was then centrifuged at 37,000 x ~ 
for 1 hr in the Sorvall centrifuge with the SS-34 rotor. The 0.05 % NP-
40 extract (Fraction c2) was removed by pipette and discarded, and the 
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remaining membrane (Fraction Cl) was resuspended Ln 4 volumes of buffer 
c. In the second step, NP-40 was added to Fraction C1 to a final concen-
tration of 0.7 %. Addition of the detergent, homogenization, and centri-
fugation were repeated as described in step 1. The resulting supernatant 
(Fraction D) containing the 0.7% NP-40 membrane extract was decanted. 
This light brown, slightly opaque solution was used fresh for further 
purification of the 5'-deiodinase or stored in capped vials in 10 mL ali-
quots at -60 •c. When stored in this manner, Fraction D could be kept 
for up to 1 month with little or no loss of catalytic activity. The 
remaining unsolubilized membrane (Fraction E) was discarded. 
The quantity of detergent solution (B mL) added in the second step 
was calculated from the following formula with the aid of a Texas Instru-
(:~)· A ( A • a%) b% 
B = -----------------------
( c%) 1 - b% 
ments TI-59 programmable calculator. The equation was derived from the 
formula: (A mL • a%) + (B mL • bi.) = (C mL • ci.), with the assumption 
that A + B = C. The terms are defined as follows: A= mL homogenate; B 
= mL detergent to be added (unknown); and C = mL of final volume (un-
known). The small case letters (a, b, anc c) represent concent~ations of 
the extract already or to be added to each of the respective solutions. 
Purification of Nonidet P-40 Solubilized Iodothyronine 5'-Deiodinase 
Purification techniques attempted but not used in the procedure for 
the purification of the Fraction D 5'-deiodinase included: salt frac-
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tionation with ammonium sulfate (Weir, 1973), and fractionation with 
polyethylene glycol (Chesebro and Svehag, 1968). A 5-fold dilution of 
Fraction D, was used for cationic exchange cellulose chromatography with 
carboxymethyl (CM) cellulose (Wharton and McCarty, 1972), affinity chrom-
atography with Affi-Gel 401 (Brocklehurst~~., 1974), and 
organomercurial-Sepharose 4B (Sluyterm and Wijdenes, 1974) and lectin 
binding chromatography with Concanavalin A-Sephrose 4B (Norden and 
O'Brian, 1974). These techniques were performed on Fraction Din buffer 
C as previously described, with minor modifications. All steps were 
carried out at 4 °C with the exception of Concanavalin A column elution 
which was performed at room temperature. All samples were stored at 4 °C 
or on ice prior to dete~ination of enzyme catalytic activity. Concen-
trations of reagents used, and a description of the effectiveness of each 
technique are given in the Results section. 
DEAE Cellulose chromatography was performed for the initial purifi-
cation of the Fraction D preparation. DEAE Cellulose was prepared fresh 
or regenerated after previous usages by the method of Brewer (1974). A 
2.4 x 14 em column of cellulose, equilibrated in buffer D, having a bed 
volume of 55 mL was prepared at least 16 h prior to use. Fracti0n D in a 
20-25 mL aliquot containing from 350 to 400 mg of protein was applied to 
the cellulose column at a flow rate of 40 mL/h. Following addition of 
the enzyme preparation, the column was washed with buffer D until the 
A280 dropped to base line. Typically, this required approximately 3 to 4 
bed volumes of buffer D. Elution of the bound protein was performed ~n 
either a stepwise manner or with a linear gradient by increasing the con-
centration of salt in buffer D from 10 to 500 mmol/L NaCl. Individual 
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fractions were divided into 3 pools: Pool 1 contained the proteins that 
eluted with the sample front. Pool 2 (Fraction I) contained the majority 
of the 5'-deiodinase, and consisted of those fractions collected follow-
ing the initial drop of Azgo, but prior to the addition of NaCl. Pool 3 
was the NaCl eluted protein. 
Fraction I from the cellulose chromatography step was added in a 
ratio of 3.4 mg protein : 1 mL hydroxylapatite gel to a beaker and stir-
red slowly (to avoid foaming) for 16 h. Following the batchwise adsorp-
tion, the hydroxylapatite gel was recovered by centrifugation of the 
slurry at 1,000 x £ for 10 min, and the recovered hydroxylapatite was 
poured into a 2.4 x 16 em column for column chromatography. The column 
was washed with buffe~ F at a flow rate of 20 mL/h until the effluent was 
free of protein and then eluted with a step gradient of increasing KHzP04 
concentration. The step gradient was made by diluting buffer G with buf-
fer F to give solutions of: 50, 125, and 400 mmol/L KH2Po4. Approxi-
mately 5 bed volumes of each elution buffer were applied to the column 
and the fractions collected at a concentration of 125 mmol/L phosphate 
were pooled together for the Fraction II enzyme preparation. 
A Sephadex G-25 gel filtration column (2.6 x 90 em) equilibrated ~n 
buffer F was used to desalt Fraction II. Sample volumes of up to 65 mL 
were applied to the 300 mL bed volume column at a flow rate of 70 mL/h, 
and the effluent fraction containing 5'-deiodinase activity were pooled 
and concentrated on a mini-column (3 mL bed volume) of hydroxylapatite 
equilibrated ~n buffer F. The desalted enzyme solution was applied at a 
flow rate of 12 mL/h, and the adsorbed protein was recovered with a 300 
mmol/L phosphate elution buffer at a flow rate of 4 mL/h. This technique 
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allowed the partially purified enzyme to be recovered in a volume of 
approximately 6 mL. 
A Sepharose 6B-CL gel filtration column (1.5 x 98.5 em) was used 
for the third step in the purification sequence. Fraction II concentrate 
was applied to the column in 3 to 6 mL aliquots, and chromatography in 
buffer H was performed at a flow rate of 20 mL/h. Fractions were col-
lected and assayed for thyroxine 5'-deiodinase activity. Those fractions 
containing high concentrations of activity were pooled and labeled as 
Fraction III. This fraction was stored in tightly closed vials at 4 °C 
prior to use in characterization studies. 
Isoelectric Focusing 
-Isoelectric focusing of the Fraction III iodothyronine 5'-deiodi-
nase was performed at 4 °C in a 110 mL electrofocusing column mounted ~n 
a vertical position. When the cathode was used at the bottom of the 
column the column was prepared in the following manner: 12.5 mL of the 
cathode buffer were added into the center chamber of the column. The LKB 
gradient mixer was used to develop the sucrose gradient as 55 mL of the 
heavy gradient solution and 55 mL of the light gradient solution, con-
taining the protein sample were added to the column. Following the addi-
tion of the sucrose gradient, 12.5 mL of the anode buffer were added to 
the top of the gradient. Electrophoresis was begun, following the re-
lease of the cathode chamber plug, by adjusting the power source to de-
liver an initial output of 200 v. The voltage was gradually increased to 
400 v keeping the wattage below 1.5 watts throughout the run. The vo1-
tage was increased to 350 v after 10 h and to 400 v after 19 h. The 
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column was developed an additional 26 h at 400 v. Prior to turning off 
the voltage, the amperage had stabilized to 1.4 ma for 3 h. The plug was 
used to close off the cathode chamber and the column was eluted. 
The sucrose gradient was eluted at a rate of 2 mL/min with the aid 
of a peristaltic pump. The column effluent was collected in 1.5 mL frac-
tions and immediately following the collection of the effluent, the indi-
vidual fractions were covered with Parafilm and placed on ice. The pH of 
each fraction was measured with a digital pH meter standardized with buf-
fers at 0-4 °C. The protein concentration and activity of the iodothy-
ronine 5'-deiodinase were also determined for each fraction. 
Reagents for Isoelectric Focusing: 
Anode Buffer. 100 ~L of 85 % phosphoric acid, 125 ~L of 10 % Non-
idet P-40, and 625 ~L of 100 mmol/L dithiothreitol were diluted to 
12.5 mL with deionized water. 
Cathode Buffer. 5.725 g sucrose, 1.25 mL of 10% NaOH, 125 ~L 10% 
Nonidet P-40, and 625 ~L of 100 mmol/L dithiothreitol were diluted 
to 12.5 mL with deionized water. 
Light Gradient Solution. 10 mL of protein sample (Fraction III), 
1.25 mL of ampholytes (3/10), 0.6 mL of 10% Nonidet P-40, and 3.0 
mL of 100 mmol/L dithiothreitol were dissolved in deionized water 
and diluted to a final volume of 60 mL. 
Heavy Gradient Solution. 28.0 g sucrose, 3.75 mL ampholytes 
(3/10), 0.6 mL 10% Nonidet P-40, 3.0 mL of 100 mmol/L dithio-
threitol were diluted to a final volume of 60 ml with deionized 
water. 
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Molecular Weight Determination 
The apparent molecular weight of the detergent solubilized iodothy-
ronine 5'-deiodinase was approximated by analytical gel filtration 
chromatography. A Sephacryl S-300 superfine column (1.5 x 98.4 em) was 
calibrated with the Pharmacia low molecular weight and high molecular 
weight calibration kits according to manufacturers recommendations. The 
following protein standards were used: ribonuclease A (13,700 daltons), 
chymotrypsinogen A (25,000 daltons), ovalbumin (43,000 daltons), bovine 
serum albumin (67,000 daltons), aldolase (158,000 daltons), catalase 
(232,000 daltons), ferritin (440,000) daltons), and thyroglobulin 
(669,000 daltons). Blue dextran 2,000 was used to determine the void 
volume. Chromatography of both protein standards and enzyme preparations 
was performed in column buffer H (4 °C) at a rate of 12 mL/h. Gel fil-
tration chromatography with the above standards was also performed on a 
Sephadex G-200 column (1.5 x 96 em) and the Sepharose 6B-CL column (1.5 x 
98 em). 
The approximate molecular weight of the iodothyronine 5'-deiodinase 
was determined from a plot of the log molecular weight versus the Kav of 
each standard. The Kav was determined from the equation Kav = (Ve -V0 )/ 
(Vt -V0 ); where Ve is the elution volume for the protein, V0 is the void 
volume as determined by blue dextran, and Vt is the total bed volume of 
the gel. In addition to relating the elution volume of the enzyme to the 
protein standards to determine an approximate molecular weight for the 
enzyme, a plot of -log Kav versus the Stokes' radius was also used to 
approximate the molecular size of the solutilized enzyme. 
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Enzymatic Assays With 125r-T4 and 125I-rT3 Substrates 
The 5'-deiodination of 125I-labeled T4 and rT3 by the Fraction D 
and Fraction III enzyme preparations was carried out under standard 
enzyme assay conditions with the exception that the pH for the deiodina-
tion of rT3 was increased to pH 7.5 and the addition of radiolabeled sub-
strates were added to the incubation mixture. The T4 and rT3 substrate 
solutions contained 6.5 ~g T4 + 0.0572 ~Ci l25I-T4/100 ~L and 5.0 ~g rT3 
+ 0.0092 ~Ci 125I-rT3/100 ~L, respectively. Prior to use, the radio-
labeled substrates were purified by Sephadex G-25 column chromatography 
according to the method of Green (1972). The reaction was stopped with 
the addition of 50 ~L of a solution containing 2 mol/L NaOH and 5 mol/L 
NaCl rather than 1.0 mL of the reagent alcohol. This resulted in a final 
pH of 12.5 or higher. The percent 125I-T4 and 125I-rT3 deiodinated was 
determined by separating the substrates and products of the reaction mix-
ture by Sephadex G-25 column chromatography (Green, 1972; Burman!!~·' 
1977) and counting the radioactivity in each of the peaks. 
Sephadex G-25 chromatography was performed in 0.8 x 19 em columns 
(10.0 mL bed volume) at a flow rate of approximately 20 mL/h. The sample 
was added in a solution having a final concentration of 0.015 mol/L NaOH, 
0.5 mol/L NaCl. The column buffer was 0.1 mol/L NaOH, 0.005 mol/L NaCl. 
A sample volume of 400 ~L was applied and fraction volumes of 1.03 mL 
were collected. The void volume was 5.0 mL. Free iodide (125I) eluted 
1n a sharp peak (8-12 mL) with an elution volume Ve of 10.0 mL. l25r-T3 
and the rT3 metabolite (3,3'-T2) eluted in a sharp peak (15 to 20 mL) 
with a ve of 17.0 mL. 125I-T4 and 125I-rT3 eluted 1n a broad peak (22-30 
mL) with a Ve of 25.5 mL. A single column run required approximately 90 
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min to complete. The columns demonstrated excellent reproducibility and 
sample recovery was essentially complete. 
CHAPTER III 
RESULTS 
Subcellular Fractionation 
The subcellular distribution of iodothyronine 5'-deiodinase in rat 
liver cells was studied by differential centrifugation as described in 
METHODS. The results are presented in Table 2. Deiodinase activity was 
found in all fractions studied. The fraction with the least amount of 
activity was the 78,000 x £supernatant. Of the particulate enzyme 
fractions, the greatest concentrations of 5'-deiodinase activity were 
found in the crude microsomal and crude nuclear fractions. 
The crude microsomal fraction (Fraction P) and the crude nuclear 
fraction (Fraction N) were further subdivided by ultracentrifugation in a 
discountinuous sucrose gradient. When the resulting plasma membrane sub·-
fractions were assayed for 5'-deiodinase activity, it was found that t~e 
deiodinase was distributed throughout the membrane fractions rather than 
being predominately associated with any one fraction. The subfraction 
with the greatest yield of deiodinase activity was the microsomal en-
riched fraction (Fraction P4) which had a 30 % yield of 5'-deiodinase 
activity and a 2.5-fold increase Ln specific activity. An additional 38 
% of the deiodinase activity was recovered 1n Fractions: N2, N3, P2 and 
P3, as shown in Table 2. The subfractions of greatest specific activity 
were the plasma membrane fractions (N2) and (P2) and the endoplasmic 
reticulum enriched plasma membrane fraction (P3), which had relative 
specific activities of 6.1, 6.8, and 10.1, respectively. 
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Table 2 
Distribution of Iodothyronine 5'-Deiodinase Activity Following 
Subcellular Fractionation of Rat Liver Homogenate 
5 '-DEIODINASE 
PROTEIN ACTIVITY 
FRACTION (% of total) (% of total) RSA* (n)** 
(N) Nuclei 17.6 ± 4.3 30.5 ± 6. 0 1.73 ± 0.62 6 
(1,000 x £pellet) 
(M + L) Mitochondria plus 15.2 ± 2.8 13.4 ± 4.1 0.88 ± 0.28 6 
Lysosomes (33,000 x g 
pellet) -
(P) Microsomes 14.1 ± 2.8 48.2 ± 8.7 3.42 ± 1.03 6 
( 78,000 X£ pellet) 
(S) Cytosol 48.0 :f 3. 7 6.8 ± 3.1 0.14 ± 0.03 9 
(78 ,000 x £ supernate) 
Recovery From Homogenate: 94.9 ± 8 98.9 ± 14 
(N2) Plasma Membrane (pm) 1.7 10.3 6.1 2 
(N3) pm + Mitochondria 7.6 9.1 1.2 2 
(N4) Nuclei 8.2 8.8 1.1 2 
Recovery From Fraction N: 17.5 28.2 
(P2) Plasma Membrane 1.2 8.2 6.8 2 
(P3) pm + Endoplasmic 1.0 10.1 10.1 2 
Reticulum 
(P4) pm + Microsomes 11.9 29.5 2.5 2 
Recovery From Fraction P: 14.1 47.8 
Data are mean ± standard deviation, or the average of duplicate 
determinations. 
* RSA = Relative Specific Activity (RSA of the crude homogenate = 1.0). 
** (n) = number of fractionation runs. 
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Solubilization of Iodothyronine 5'-Deiodinase 
Results from the subcellular fractionation study indicated that the 
iodothyronine 5'-deiodinase was primarily a particulate enzyme and, 
therefore, that membrane extraction would be required prior to purifi-
cation. A crude membrane preparation (Fraction C) was used as the start-
ing material and several techniques for the solubilization of the 5 1 -
deiodinase were evaluated. 
Two physical methods were attempted to extract the enzyme. Exten-
sive membrane homogenization with Potter-Elvehjem or Dounce homogenizers 
did not increase the yield of soluble 5'-deiodinase activity signifi-
cantly. When Fraction C was subjected to 8 freeze-thaw cycles, 10 %or 
less of the total particulate activity was extracted. 
A number of chemical extraction techniques were also investigated. 
Acid ~xtraction failed to solubilize the 5'-deiodinase and at pH's below 
5.8 resulted in a sharp decrease in recoverable particulate activity. 
Alkali treatment also failed to extract the enzyme, and resulted in a 
more gradual decrease in the recovery of particulate activity. This de-
c~ease became more prominent above pH 7.8. Neither n-butanol nor ethanol 
were ~ffective in extracting active enzyme from Fraction C when solvent 
concentrations of from 0.1 %to 5.0% were tested. The enzyme was comr 
pletely inactivated by extraction at 4 °C with concentrations of n-
butanol greater than 4.0 %. The inactivation of the enzyme during etha-
nol extraction at 4 °C was less severe, but still approached 50 % at an 
ethanol concentration of 5.0 %. 
Enzymatic digestion of Fraction C with pancreatic lipase (0.02-
0.16% did not extract protein or 5'-deiodinase activity. At a lipase 
concentration of 0.32 %, approximately 20 % of the protein content of 
Fraction C was released. Higher concentrations of lipase released 
greater amounts of protein, however, 5'-deiodinase activity was not ob-
served in the lipase extracts at any of the concentrations tested. 
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Detergent solubilization of the crude membrane preparation with the 
a~ionic detergent, deoxycholate (DOC); the nonionic detergent, Triton X-
100 (TX-100); Nonidet P-40 (NP-40); and zwittericnic detergents (Zwitter-
gents: 3-08, 3-10,· 3-12, 3-14, and 3-16) was also evaluated. The solu-
bilization of the crude membrane preparation to clarity with the dropwise 
addition of a 10 % solution of DOC resulted in a complete loss of deiodi-
nase activity. A partial reactivation of the 5'-deiodinase could be 
achieved by removing DOC via Sephadex G-25 filtration, however, the yield 
of solubilized enzyme activity from Fraction C was less than 16 % using 
this technique. When DOC concentrations of 0.18, 0.30, 0.60, and 0.80% 
were used the yields of solubilized activity were: 18, 24, 8, and 2 %, 
respectively (assayed in the presence of DOC). The solubilization of 
Fraction C with several nonionic and zwitterionic detergents at final 
detergent concentrations of 0.3 % gave the following results when enzyme 
assays were carried out in the presence of the solubilizing detergent: 
Triton X-100 solubilized 64 % of the protein and 30 % of the deiodinase 
activity, NP-40 solubilized 68 % of the protein and 41 % of the deiodi-
nase activity, and the Zwittergents: 3-08, 3-10, 3-12, 3-14, and 3-16 
solubilized 35, 55, 70, 80, and 53 % of the protein respectively and 4, 
22, 28, 14, and 16 % of the deiodinase activity respectively from Frac-
tion C. Further experiments using combinations of DOC and NP-40, and 
combinations of the Zwittergents and NP-40 did not increase the yield of 
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solubilized 5'-deiodinase. 
Based on the results of the extraction techniques presented above, 
detergent solubilization with NP-40 was chosen as the most suitable 
method for the extraction of active iodothyronine 5'-deiodinase from 
crude rat liver membrane preparations. To determine the conditions 
necessary to selectively solubilize the 5'-deiodinase, further experi-
ments were conducted to study the effect of detergent concentrations on 
membrane solubilization. The results are presented in Figures 6 and 7. 
Homogenization of Fraction C with 0.05 % NP-40 solubilized 55 % of the 
protein and 4.6 %of the 5'-deiodinase activity. Protein solubilization 
reached a plateau above 0.4% detergent and solubilization with 0.7% 
detergent extracted 78 % of the protein from Fraction C and resulted in a 
60% yield of solubilized 5'-deiodinase activity. The apparent inactiv-
ation of the total 5'-deiodinase activity in the presence of increasing 
concentrations of detergent (Figure 7) could not be reversed by detergent 
removal and, therefore, limited the maximum yield of solubilized enzyme 
activity to approximately 60 % of that present in Fraction C. 
Other experiments demonstrated that the yield of active 5'-
deiodinase was dependent on the pH of the extraction buffer. The optimum 
pH for solubilization with NP-40 was found to be in the range of pH 7.0 
to 7.5. 
Purification of Iodothyronine 5'-Deiodinase 
Preliminary experiments were performed to evaluate several purifi-
cation techniques as to their potential usefulness in the purification of 
the crude NP-40 solubilized deiodinase (Fraction D). These techniques 
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Figure 6. Effect of Nonidet P-40 concentration on the solubilization of 
protein from rat liver membranes. 
Varying quant~t~es of detergent were .added (4 °C) in a dropwise 
manner with stirring to.a sample of Fraction C containing 65 mg of pro-
tein. The final volume was adjusted to 10 mL with homogenate buffer (pH 
7.35), and the mixture was homogenized in the Dounce homogenizer with 12 
strokes of pestle A. The soluble protein was separated from the pellet 
following centrifugation (37,000 x g, 45 min). The solubilized protein 
(o), unsolubilized protein (£0 and total protein (e) are plotted as a 
function of Nonidet P-40 concentration. Data are the averages of dupli-
cate determinations. 
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Figure 7. Effect of Nonidet P-40 concentration on the solubilization of 
iodothyronine 5'-deiodinase activity from rat liver membranes. 
Varying quant1t1es of detergent were added (4 °C) in a dropwise 
manner with stirring to a sample of Fraction C containing 63 mg of pro-
tein. The final volume was adjusted to 10 mL with homogenate buffer (pH 
7.35), and the mixture was homogenized in the Dounce homogenizer with 12 
strokes of pestle A. The solubilized protei~s were separated from the 
pellet following centrifugation (37,000 x g, 45 min). T4 to T3 conver-
ting activity in the solubilized extracts tO) and in the pellet ~ was 
determined by standard 5'-deiodinase assay conditions (See MATERIALS AND 
METHODS). The detergent concentration for all samples was adjusted to 
0.1 % NP-40 prior to enzyme assay. Total activity (e) is the sum of 
solubilized and pellet activities. Data are the averages of duplicate 
determinations. 
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included.affinity chromatography, ion exchange chromatography, chromato-
graphy using.hydroxylapatite, gel filtration chromatography and fraction-
ation with ammonium sulfate and polyethylene glycol. Additional experi-
ments were also performed to evaluate methods for desalting and concen-
trating solutions of the enzyme. 
When the crude NP-40 solubilized preparation was applied to a col-
umn of Concanavalin A-Sepharose 4B, 88 % of the 5'-deiodinase and 93 % of 
the protein passed through the column unadsorbed. Elution of the column 
with 750 mmol/L alpha-methyl-mannoside resulted in the recovery of the 
remaining 7 % protein, but no additional 5'-deiodinase activity. The 
total recovery of 5'-deiodinase was 88 %. In experiments using an Affi• 
Gel 401 sulfhydryl-binding affinity column, an average 72 % of the ap-
plied enzYme and 97 % of the applied protein was recovered in the unbound 
fraction. An additional 3-8 %of the 5'-deiodinase and the remaining 3 % 
protein was recovered by elution with SO mmol/L 1-cysteine. The total 
recovery of 5'-deiodinase activity from the Affi•Gel column was approxi-
mately 77 %. When an organomercurial Sepharose 4B resin was used as a 
sulfhydryl-binding adsorbent, approximately 18 % of the applied deiodi-
nase and 56 % of the applied protein did not bind to the column. When 
the column was eluted with 50 mmol/L L-cysteine, 25 % of the 5'-
-
deiodinase activity and 44 % of the protein were recovered. The total 
recovery of 5'-deiodinase activity was 43 %. A similar yield of enzyme 
activity and protein were obtained when the organomercurial column was 
eluted with 25 mmol/L dithiothreitol. 
Both cation and anion exchange celluloses were used to evaluate ion 
exchange chromatography of the crude NP-40 solubilized 5'-deiodinase. 
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During cation exchange chromatography of Fraction D on CM cellulose equi-
librated to pH 6.4, the unadsorbed protein eluted from the column in an 
initial sharp peak containing 64 % of the deiodinase activity and 70 % of 
the protein. A second smaller peak of unadsorbed protein trailed behind 
the first and contained an additional 18 % of the deiodinase and 22 % of 
the protein from the applied sample. Elution of the adsorbed protein 
with 350 mmol/L NaCl resulted in the recovery of 6 % of the enzyme and 8 
% of the protein. The total recovery of protein was 98 %, and the total 
recovery of enzyme activity was 88 %. Elution with increased concentra-
tions of NaCl failed to recover additional activity from the column. 
Chromatography at pH's less than 6.4 resulted in decreased recoveries of 
enzyme activity due to the tendency of the detergent solubilized 5'-
deiodinase to precipitate under acidic conditions. 
Anion exchange chromatography was performed using DEAE cellulose. 
Maximum recovery of enzyme activity occured when the column and sample 
were equilibrated to pH 7.6. The majority of the unadsorbed protein 
eluted from the DEAE cellulose column ~n a sharp peak containing approxi-
mately 20-30 % of the applied protein and 10-30 % of the applied deiodi-
nase. Following the initial peak of unadsorbed protein, small amounts of 
protein eluted as the column was washed with buffer. This trailing peak 
contained 8-15 %of the applied protein and 50-65 % of the applied 5'-
deiodinase activity. In a typical run, 20 % of the applied enzyme and 65 
% of the applied protein adsorbed to the column matrix. When a linear 
gradient of increasing NaCl concentration was then applied to the column, 
additional 5'-deiodinase activity eluted from the column in amounts pro-
portional to the peaks and troughs of the total protein elution pattern. 
69 
The largest peak of 5'-deiodinase activity was eluted at a NaCl concen-
tration of 100 mmol/L. The specific activity of this peak was calculated 
to be 0.12 relative to 1.0 for the crude Fraction A, and 1.29 for the ap-
plied sample. In a typical run, the total recovery of protein was ap-
proximately 100 %, and the total recovery of deiodinase activity was in 
the range of from 120-130 %, suggesting that a mild activation of the 5'-
deiodinase occured during the DEAE cellulose step. 
Further experiments with DEAE cellulose demonstrated that the 5'-
deiodinase had a low affinity for the diethylaminoethyl ligand of the 
cellulose matrix at pH 7.6. When a previously adsorbed peak was pooled, 
desalted, and reapplied to DEAE cellulose, 43 % of the enzyme and 86 % of 
the protein readsorbed. The remainder of the sample eluted in a single 
broad peak with the low ionic strength column buffer. When the unad-
sorbed activity was pooled and reapplied, an additional 4 % of the enzyme 
and 9 % of the protein adsorbed to the DEAE cellulose. 
Addition of the crude NP-40 solubilized membrane extract to a hy-
droxylapatite column resulted in the adsorption of 94 % of the applied 
enzyme and 72 % of the applied protein. Elution of the adsorbed enzyme 
from the hydroxylapatite column with a linear gradient of increasing 
phospage concentration, resulted in a broad wavy peak of 5'-deiodinase 
activity which coincided with the bulk of the eluted protein. In a simi-
lar manner, elution of the enzyme from the hydroxylapatite column with a 
step gradient resulted in elution of enzyme activity over a broad range 
of phosphate concentrations in such a manner that there was no signifi-
cant increase in specific activity for any of the peaks obtained. A sin-
gle sharp peak of activity could be recovered from the hydroxylapatite 
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column, however, when the applied sample had been previously purified by 
DEAE cellulose chromatography. Elution of the partially purified 5'-
deiodinase from the hydroxylapatite column with a linear phosphate gradi-
ent resulted in the recovery of 76 % of the applied enzyme within a con-
centration range of 90 to 150 mmol/L phosphate. Elution of the partially 
purified enzyme with a step gradient of: 100, 150, 200 and 300 mmol/L 
phosphate resulted in the recovery of: 49.3, 19.9, 11.3, and 15.5 %, re-
spectively of the applied enzyme activity and 11.1, 16.9, 24.4, and 21.0 
%, respectively of the applied protein. The 100 mmol/L phosphat~ step 
resulted in a 4.4-fold increase in specific activity. Approximately 24 % 
of the protein and 4 % of the enzyme did not adsorb to the hydroxylapa-
tite column. 
Gel filtration chromatography of the crude NP-40 solubilized mem-
brane extract was performed on columns of Sephadex G-100 and Sepharose 
6B-CL. When the detergent extract was added to Sephadex G-100, and chro-
matographed in the presence of detergent, 98 % of the deiodinase activity 
and 42 % of the protein from the sample eluted 1n the void volume. The 
included volume contained 58 % of the sample protein and no deiodi3ase 
activity. When the detergent extract was applied to Sepharose 6B-CL, 6 % 
of the deiodinase eluted in the void volume, 11 % eluted as a large mole-
cular weight complex in excess of 400,000, and 54 % was recovered in a 
symmetrical peak corresponding to an average molecular weight of 280,000. 
The total recovery of 5'-deiodinase activity was 71 %. The protein elu-
ted in skewed fashion towards the lower molecular weight range and the 
purification of the major activity peak was estimated to be 2.4-fold. 
Gel filtration was normally performed with a column buffer containing 
0.1 % NP-40 detergent. In the absence of detergent, the 5'-deiodinase 
eluted from the Sepharose 6B-CL column in the void volume. 
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Fractionation of the NP-40 membrane extract with ammonium sulfate 
and polyethylene glycol resulted in yields of activity in the range of 30 
to 50 %. The losses of enzymatic activity appeared to be due to the in-
complete resolubilization of the precipitated protein. Ammonium sulfate 
pr~cipitated 80 %of the 5'-deiodinase activity at 45 % saturation (4 •c) 
with a resulting 1.8-fold purification. Fractionation with polyethylene 
glycol at concentrations of from 10-12 % precipitated 80 % of the activ-
ity, however, due to the loss in recoverable activity and a near complete 
precipitation of protein, a decrease rather than an increase in specific 
activity was observed. 
Desalting of 5 1 -deiodinase solutions was performed either by dialy-
s~s or by Sephadex G-25 gel filtration. Dialysis overnight in hydroxyla-
patite column buffer at 4 °C resulted in a 30-50 % loss in activity comr 
pared to a 0-10 % loss in activity using the Sephadex G-25 column. An 
additional advantage of using Sephadex G-25 chromatography was that it 
took less time. 
When the NP-40 solubilized 5 1 -deiodinase was concentrated with an 
Amicon concentrator using a PM-30 membran~ (30,000 molecular weight cut-
off) at 4 °C, a 10-fold concentration was accompanied by a 90 % loss of 
activity. When mini-columns of hydroxylapatite were used for concentra-
tion, approximately 5 mg of protein was adsorbed per mL of hydroxylapa-
tite resin and the 5'-deiodinase activity was recovered by eluting the 
columns with small volumes of 350 mmol/L phosphate elution buffer. The 
recovery of activity by this method was approximately 100 %. 
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The Purification Procedure 
A multistep purification procedure (Figure 8) was developed based 
on detergent solubilization with Nonidet P-40 and the combined use of 
three separation techniques that gave promising results in the pilot 
studies described above. Each technique was optimized using the purified 
product from the previous step. Twelve different preparations were 
carried through the procedure. The results described below, for a single 
purification attempt, are characteristic of my experience with each step, 
and the overall purification scheme. 
Preparation of Solubilized Iodothyronine S'-Deiodinase 
The crude rat liver homogenate (Fraction A) was prepared for solu-
bilization as described in the Materials and Methods section. An initial 
high speed centrifugation step was used to remove the cell cytosol (Frac-
tion B). The remaining membrane pellet (Fraction C) retained 92% of the 
5'-deiodinase activity and 53 %of the protein from Fraction A. This 
initial purification of the crude homogenate resulted in a 1.7-fold in-
crease in specific activity. Following the removal of the cell cytosol, 
a 2 step selective solubilization of Fraction C was performed with Non-
idet P-40. In the first step, Fraction C was homogenized with 0.05 % NP-
40. This step solubilized 53 % of the remaining protein and 5 % of the 
5'-deiodinase. The extract (Fraction c2) was discarded. In the second 
step, the washed membrane pellet (Fraction c1) was homogenized with a 
final 0.7 i. NP-40. Approximately 60% of the activity was solubilized 
membrane fraction (Fraction E). The use of 0.7% detergent resulted in a 
20% loss in total activity from Fraction c1 • The recovery of total 
Figure 8. Flow diagram for the solubilization and purification of 
iodothyronine 5'-deiodinase from rat liver homogenate. 
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0.7% NP-40 
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11 hr 4 °C 
I 0.05 % NP-40 
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~1 Membrane 
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37,000 X g 
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0.7% NP-40 
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protein and total 5'-deiodinase activity from Fraction A is shown in 
Table 3. 
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The solubilized membrane extract (Fraction D) contained 20 % of the 
protein and 49 % of the activity of Fraction A, corresponding to a 2.4-
fold increase in specific activity. Upon visual inspection, Fraction D 
was a slightly viscous, dark brown, turbid solution. The 5'-deiodinase 
activity did not sediment when centrifuged for 60 min at 77,000 x £, 
however, the activity was rapidly precipitated when the pH of Fraction D 
was adjusted to pH 5.8 or below. Fraction D could be stored frozen at 
-60 °C for up to 6 weeks without a detectable loss 1n 5'-deiodinase 
activity. 
DEAE Cellulose Chromatography 
DEAE cellulose chromatography was used as the first step in the 
purification of Fraction D. The elution profile of protein and 5'-
deiodinase activity from the DEAE cellulose column is shown in Figure 9. 
The optimum performance of this step occured at pH 7.6. The flow rate 
was not critical to the performance of the column as long as the sample 
front migrated evenly. The packing of the column, however, was a major 
factor. For optimum performance, the cellulose resin was prepared in 
large batches which were equilibrated in column buffer, and the columns 
were poured at least 16 h prior to use (See MATERIALS AND METHODS). A 
sample volume of up to 40 % of the bed volume could be applied and as 
much as 12 mg protein were adsorbed per milliliter of cellulose. 
Approximately 65 % of the protein content of Fraction D and 23 % of 
the 5'-deiodinase activity adsorbed to the cellulose resin. Of the 35 % 
Table 3 
Preparation of Nonidet P-40 Solubilized 
Iodothyronine 5'-Deiodinase 
5 I -DEIODINASE 
NONIDET P-40 PROTEIN ACTIVITY 
FRACTION* (g/100 mL) (% YIELD) (% YIELD) 
A** 100 100 
B 47 8 
c 53 92 
c1 0.05 25 85 
c2 0.05 28 5 
D 0.70 20 49 
E 0.70 5 19 
* See Figure 8 for flow diagram of solubilization. 
**Fraction A from 70 g of rat liver tissue contained 7.08 g of protein 
and 3,737 units (pmol T3 min-lmg-1) of iodothyronine 5'-deiodinase 
activity. 
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Figure 9. DEAE cellulose column chromatography of Fraction D. 
120 mL of Fraction D was applied in 30 mL portions to 4 separate 
columns containing 2.4 x 16 em beds (68 mL) of DEAE cellulose. Chromato-
graphy in each of the 4 columns was performed (4 °C) at a rate of 40 
mL/h. Following elution of the bulk of unadsorbed protein (0-100 mL), 
Fraction I, as indicated by the bar (~), was collected with an addi-
tional 3 bed volumes (205 mL) of column buffer. At the arrow(+), 500 
mmol/L NaCl was added to the column buffer to elute the adsorbed pro-
tein. 
>
 
:t= 
0 0 CD 
U
) 
0 c: 
•
 
"0 
0 
c: 
·a; 
CD 
~
0
 
ln 0. 
I I 
0 
H
 
z 0 1-u <( 
0:: 
LL.. 
N
13l0tld 
1.0 
.
 
.
 
.
 
.
 
.
 
' 
0 0 v 0 0 ro 
0 0 (\,1 
,o
 
:-o 
l !-! 
\\ ! i 
--~--~--~--~------~--~--· lo 
ro 
~
 
~
 
1.0 
~
 
~
 
N
 
o
 
( l-lW
 1
_u!W £1 JOW d) 
A.ll/\11~~ 
3S'1N
IQ
0130-.£ 
77 
--E 
-1-z LLJ 
:;) 
.
.
.
.J 
LL.. 
LL.. 
LLJ 
78 
protein that did not adsorb, 26 % eluted in the first 80 mL of effluent 
along with 26 % of the 5'-deiodinase activity and the rema~ning 9 % elu-
ted when an additional 205 mL of column buffer was applied. This inter-
mediate peak (Fraction I) contained 77 % of the recovered 5'-deiodinase 
activity. The total recovery of protein was approximately 100 % and the 
total recovery of enzymatic acti•rity was approximately 127 %. The DEAE 
cellulose step resulted in a 9-fold purification of Fraction D. In com-
parison to the crude rat liver homogenate (Fraction A), Fraction I con-
tained 1.7 %and 38 %of the original protein and 5'-deiodinase activity 
respectively, corresponding to a net 22-fold increase in specific activ-
ity. 
Hydroxylapatite Chromatography 
Due to the large volume of Fraction I (820 mL) and the slow flow 
rate (20 mL/h) of the hydroxylapatite column, Fraction I was applied to 
the hydroxylapatite gel by batch adsorption. The quantity of gel added 
was ·adjusted so that there would be no more than 4.0 mg protein/mL hydro-
xylapatite. The gel slurry was subsequently recovered by low speed cen-
trifugation and packed into a column. The enzyme was eluted with a step 
gradient of increasing phosphate concentration (See Figure 10). 
Approximately 16 % of the protein from Fraction I did not adsorb to 
the hydroxylapatite gel. There was no detectable unadsorbed enzyme ac-
tiv~ty. Elution of the adsorbed protein was carried out 1n 3 steps: The 
50 mmol/L phosphate buffer eluted 8 % of the protein and 11 % of the 
deiodinase. Fraction II (Figure 10) was recovered with the 130 mmol/L 
phosphate elution buffer. This fraction contained 18 % of the applied 
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Figure 10. Hydroxylapatite column chromatography of Fraction I 
The combined Fraction I effluent (820 mL) from the DEAE cellulose 
chromatography step was applied to 32 mL of hydroxylapatite gel in a 1 
liter vessel prior to column chromatography. Details of the procedure 
are described in Materials and Methods. The supernatant, containing the 
unadsorbed protein was recovered following low speed centrifugation (10 
min, 1,000 x ~). The gel, containing the adsorbed protein was packed 
into a column, and the resulting· hydroxylapatite bed (2.4 x 9 em) was 
washed ~~ith 32 mL of column buffer. Elution of the adsorbed protein was 
carried out at a flow rate of 20 mL/h (4 °C) with a step gradient of 
increasing phosphate concentration. At the points indicated by the 
arrows (+), elution buffers containing: (A) 50 mmol/L, (B) 130 mmol/L 
and (C) 400 mmol/L phosphate were added to the column. The 130 mmol/L 
phosphate peak (Fraction II), as indicated by the bar (~), was pooled 
for gel filtration chromatography. 
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protein and 97 % of the applied 5'-deiodinase. The final 400 mmol/L 
phosphate step eluted 57 % of the protein and 5 % of the 5'-deiodinase. 
The recovery of protein was nearly complete and the net recovery of 5'-
deiodinase activity was 113 %. Fraction II was purified 5.3-fold with 
respect to Fraction I and 115-fold relative to the crude rat liver homo-
genate (Fraction A). A final 37% yield of 5'-deiodinase activity from 
Fraction A was achieved. 
Sepharose 6B-CL Chromatography 
Sepharose 6B-CL column chromatography of Fraction II was used for 
the final step in the purification of the iodothyronine 5'-deiodinase 
(~igure 11). Optimal performance of the gel filtration step was observed. 
when the column was run at a flow rate of 20 mL/h and when the column 
buffer contained 0.1 % NP-40. The majority of the 5'-deiodinase activity 
eluted from the column in a single sharp peak in the molecular weight 
range of 200,000 -350,000. This peak (Fraction III) contained approxi-
mately 13 % of the protein and 66 % of the 5'-deiodinase activity reco-
vered from Fraction II. No activity and very little protein was detected 
in the void volume, however, an additional 7 % of the deiodinase was re-
covered in 2 small peaks in the high molecular weight range and in a 
trailing of the major activity peak towards the low molecular weight 
range. The total recovery of enzymatic activity from Fraction II was 
approximately 73 %. The gel filtration step increased the specific 
activity 5.1-fold. 
The final preparation (Fraction III) was purified 580-fold relative 
to the crude rat liver homogenate. The overall recovery of activity was 
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Figure 11. Sepharose 6B-CL column chromatography of Fraction II. 
Fraction II from hydroxylapatite chromatography was concentrated to 
6 mL and applied to a column of Sepharose 6B-CL (1.5 x 98.5 em). Gel 
filtration chromatography was performed at a rate of 20 mL/h (4 °C). The 
bar (~) indicates those fractions pooled for Fraction III. a-e indi-
cate the peak volumes for blue dextran and the standard proteins used to 
calibrate the column: a, blue dextran; b, thyroglobulin; c, ferritin; d, 
catalase; e, aldolase. 
-
100 
T_, 
e 
•c: 
e 
r() 
1-
0 
e 
~ 
-
>-
1-
- 50 > 
1-
(.) 
<( 
w 
V) 
<( 
z 
0 
0 
LL.J 
0 
I 
tO 
0 
-· 5'-deiodinase activity" 
e----• protein 
b c 
{-~ 
d e 
t {t a t 
FRACTION !II 
0.5 
\ / '·\ 
\ '.' \ '",, 
.-·r··, ,·--·-.,, ··. I \ ~ ' 
I \ -· • '• 
,• .. - \ ',. 
l~'i . \ '·., 
.o, .!'' ~ ' r\ / I \ 
,., .. ~ ....... ~...... .,..._ .. 't( .I '\., '\ • ....... 
·-..f ~-~---·--·..,.. r '•-•-_._._._._._,.:,.., .. 
0.4 
0.3 
0.2 
0.1 
0 
~~-r~r-~~--~~--r-~~--~~--r-~ 
0 50 100 150 
EFFLUENT (ml) 
83 
-
-
-€ 
Ct 
E 
-
z 
w 
1-
0 
a:: 
a.. 
Fraction Preparation 
A Crude Rat Liver 
Homogenate 
c Crude Membrane 
Preparation 
D Solubilized 
Membrane 
I DEAE Cellulose 
II Hydroxylapatite 
III Sepharose 6B-CL 
*Units = pmol T3 min-1 
Table 4 
Purification of Iodothyronine 5'-Deiodinase 
From 70 Grams of Rat Liver 
-----Total ___ Enzyme* ___ SpeCific* Total* 
Volume Protein Concentration Activity Units of 
(mL) (mg) (units/mL) (units/mg) Activity 
250 7082 14.9 0.53 3737 
210 3753 16.4 0.92 3451 
120 1416 15.2 1.29 1823 
820 123 1.7 11.4 1408 
100 22.4 13.7 60.9 1365 
15 2.9 59.8 309 897 
Recovery Purification 
(%) 
100 
92 
39 
38 
37 
24 
Factor 
1.0 
1.7 
2.4 
21.6 
115 
583 
00 
~ 
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24% (See Table 4). The stability of the pu~ified enzyme depended on 3 
majo~ facto~s: pH, temperatu~e, and the p~esence of sulfhydryl reducing 
equivalents. The purified enzyme rapidly precipitated at pH's below 5.8 
and the 5'-deiodinase activity was not stable above pH 8.0. The 5'-deio-
dinase was mo~e stable at 4 °C than at ~oom temperatu~e, howeve~, the 
pu~ified 5'-deiodinase could not be frozen without the formation of an 
insoluble p~otein p~ecipitate. The addition of dithioth~eitol o~ mercap-
toethanol had a stabilizing effect on the activity. When F~action III 
(pH 6.5) was sto~ed in capped vials at 4 °C in the p~esence of 10 mmol/L 
me~captoethanol, up to 35 % of the 5'-deiodinase activity was lost ove~ 
a 2 week period. 
Cha~acterization of Purified Iodothy~onine 5'-Deiodinase 
Unless othe~wise indicated, the following cha~acterization studies 
were pe~formed on the purified Fraction III p~epa~ations within 2 weeks 
of their purification. Different enzyme p~eparations we~e pu~ified from 
450- to 600-fold ~elative to the crude rat liver homogenate. 
Determination of Molecula~ Weight 
When the molecula~ weight of the iodothy~onine 5'-deiodinase was 
approximated by analytical gel filtration chromatography using a Sepha-
cryl S-300 superfine column, a single sharp peak of activity eluted from 
the column between the elution volumes of catalase (232,000 daltons) and 
ferritin (440,000 daltons), and a molecular weight of 250,000 was esti-
mated for the detergent solubilized deiodinase complex on the basis of 
its elution volume relative the protein standards (Figure 12). The 
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Figure 12. Estimation of apparent molecular weight for iodothyronine 
5'-deiodinase by gel filtration chromatography on Sephacryl S-300 sf in 
the presence of 0.1 % Nonidet P-40. 
Details of the experimental procedure are described in Materials 
and Methods. The marker proteins used were: ribonuclease A (13,700), 
chymotrypsinogen A (25,000), ovalbumin (43,000), bovine serum albumin 
(67~000), aldolase (158,000), caialase (232,000), ferritin (440,000) and 
thyroglobulin (669,000). The apparent molecular weight of the NP-40 
solubilized iodothyronine 5'-deiodinase complex was estimated to be 
approximately 250,000. 
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Stokes radius of the enzyme was estimated to be 5.8 nm. The molecular 
weight of the enzyme was also estimated to be approximately 250,000 when 
chromatography was performed using Sephadex G-200 and approximately 
280,000 when chromatography was performed using Sepharose 6B-CL. 
Isoelectric Focusing of the Nonidet P-40 Solubilized 5'-Deiodinase 
The isoelectric point (pi) of the Fraction III iodothyronine S'-
deiodinase was determined by column electrofocusing in a sucrose stabi-
lized gradient of pH 3-10. The major activity peak (Figure 13) had an 
apparent pi of 7.4. Minor peaks of activity were observed in the acidic 
and basic ends of the pH gradient, however, these were considered to be 
artifactual. When the column polarity was reversed and the vertical col-
umn was run in a descending rather than an ascending manner, a single 
major activity peak with a pi of 7.4 was observed and the activity in the 
acidic range completely disappeared. As a result of denaturation during 
electrofocusing, recoveries of the Fraction III deiodinase were from 3 to 
10 %. 
Effect of pH and Temperature 
The conversion of T4 to T3 by the detergent solubilized 5'-
deiodinase was dependent on pH and temperature. The optimal pH was found 
to pH 6.5 (Figure 14,A) and the optimal temperature was determined to be 
37 °C (Figure 14,B). There was a sharp drop in activity below pH 5.8, 
and the enzyme demonstrated decreased stability above 37 °C. At 56 oc, 
the enzyme lost 50% of its activity within 3 minutes (Figure 15). A 30 
minute preincubation at 56 °C completely inactivated the 5'-deiodinase. 
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Figure 13. Isoelectric focusing of iodothyronine 5'-deiodinase in the 
presence of 0.1 % Nonidet P-40. 
Isoelectric focusing of a 3.0 mg pool of Fraction III protein on a 
sucrose gradient was performed in a 1KB 8100 electrofocusing column. The 
light gradient solution contained the sample protein, 1.25 m1 of ampho-
lytes (pH 3.5-10), 0.1 % NP-40, and 5 mmol/1 dithiothreitol in a total 
volume of 60 m1. The heavy gradient solution contained 46.6 % sucrose, 
3.75 mL ampholytes (pH 3.5-10), 0.1% NP-40, and 5mmol/1 dithiothreitol 
in a final volume of 60 m1. After forming the sucrose gradient, the sam-
ple was focused 48 hours (4 °C) at a final 400 volts, keeping power less 
than 1.5 watts throughout, and was eluted with the assistance of a peri-
staltic pump into 1.5 m1 fractions. ~ , 5~deiodinase activity; 
• • , protein concentration (Bradford); •• • • •·•• , pH. The resolved 
peak of iodothyronine 5'-deiodinase activity had a pi of 7.4. 
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Figure 14. Effect of pH and temperature on iodothyronine 5'-deiodinase 
activity. 
Enzyme assays were varied from standard reaction conditions as 
indicated. The rate of T3 formation from ~he deiodination of T4 by Frac-
tion III enzyme was plotted as the mean ± standard devi~tion for tripli-
cate determinations. A. Enzyme assays were buffered with 0.15 mol/L ci-
trate phosphate (pH 4.0-6.0), 0.15 mol/L potassium phosphate (pH 6.0-7.5) 
or 0.15 mol/L Tris-HCL (pH 7.5-9.0). In separate experiments, the 
citrate and potassium phosphate buffers gave similar results at pH 6.0, 
and the phosphate and Tris buffers gave similar results at pH 7.5. B. 
Enzyme assays were carried out in water baths thermostated to: 25, 37, 
41, 45, 51, and 56 °C. 
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Figure 15. Thermal inactivation of iodothyronine 5'-deiodinase at 56 °C. 
Preincubation of Fraction III at 56 °C was carried out for time 
intervals of 0 to 40 min. Following preincubation, aliquots of the 
.enzyme mixture were assayed at 37 °C for 30 min to determine the 
amount of T4 to T3 converting acttvtty rematntng. Data are plotted as 
the mean ± standard deviation of triplicate "determinations. 
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Linearity With Time and Protein Concentration 
A progressive increase of T3 formation with time (Figure 16, A) and 
with protein concentration (Figure 16, B) was demonstrated for the deter-
gent solubilized 5'-deiodinase. The increase with time appeared linear 
for the first 60 minutes and gradually fell off thereafter. Linearity of 
activity with protein concentration was observed when velocity determi-
nations were corrected for detergent inhibition. In contrast, activity 
of the crude rat liver homogenate Fractions A and D was not linear with 
protein concentration. Dilution of these fractions resulted in a 3- to 
5-fold increase in specific activity. 
Effect of Substrate and Detergent Concentraeion 
. 
Figure 17 shows the interrelationship of thyroxine concentration 
and NP-40 concentration on the conversion of T4 to T3 by the partially 
purified iodothyronine 5'-deiodinase (Fraction II). In the absence of 
detergent, increasing the substrate concentration from 1 ~mol/L T4 to 12 
~ol/L T4 resulted in the formation of progressively larger amounts of 
T3. Further increases above 12 ~ol/L T4 resulted in substrate inhibi-
tion. The inhibitory effect of high concentrations of T4 was decreased 
when detergent was present in the assay mixture although increasing the 
concentration of detergent also had an inhibitory effect on 5'-deiodinase 
activity. The effect of Nonidet P-40 concentration on enzyme activity at 
a constant concentration of T4 is shown in Figure 18. Nonidet P-40 at a 
concentration of 0.32 % decreased the activity by 50 %. 
In order to compare the inhibitory effect of Nonidet P-40 to that 
of deoxycholate (DOC), the activity of Fraction II in the presence of DOC 
96 
Figure 16. Linearity of iodothyronine 5'-deiodinase activity with time 
and protein concentration. 
The rate of T3 formation·from the deiodination of T4 by Fraction 
III was plotted as the mean ± standard deviation for triplicate deter-
minations. A. Enzyme assays were incubated at 37 °C for various periods 
of time from 0 to 4 hours. B. Increase in volumes of Fraction III con-
taining from 2 to 25 ~g of protein were added to the enzyme assay mixture 
----- , actual 5 '-deiodinase activity observed; , activity 
corrected for Nonidet P-40 inhibition. 
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Figure 17. Substrate saturation of iodothyronine 5'-deiodinase activity 
in the presence and absence of Nonidet P-40. 
100 ~L a1iquots of Fraction II preparations containing: o---o , 0.0 
% Nonidet P-40; e---e, 0.1 % Nonidet P-40; ~ , 0.2 % Nonidet P-40; 
and .___., 0.5 % Nonidet P-40 were added to enzyme assay mixtures of 1.0 
mL final volume. The T4 and T3 converting activity, as a function of T4 
concentration for each detergent level was plotted as the mean ± standard 
deviation for triplicate determinations. 
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Figure 18. Effect of Nonidet P-40 and deoxycholate on iodothyronine 
5'-deiodinase activity. 
100 ~L aliquots of Fraction II containing increasing concentrations 
of~onidet P-40 from 0.025 to 1.0% (w/v) or of deoxycholate from 0.05 to 
0.4 % (w/v) were incubated under standard enzyme assay conditions (1.0 mL 
final volume). Iodothyronine 5'-deiodinase activity was plotted as the 
mean ± standard deviation for triplicate determinations. e • , % 
activity in the presence of Nonidet P-40; o----o , % activity in the 
presence of deoxycholate. 
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was also studied. When DOC was added to Fraction II at concentrations 
of: 0.05, 0.1, 0.2, 0.4, and 0.8 %, the 5'-deiodinase activity was de-
creased by 64, 83, 92, and 100 %, respectively (See Figure 18). 
Activators and Inhibitors 
Several thiol group-containing compounds were found to activate the 
5'-deiodinase in a concentration dependent manner and to be essential for 
activity (Figure 19). Dithiothreitol had the greatest stimulatory ef-
feet, which plateaued at a concentration of around 20 mmol/L. Beta-
mercaptoethanol, reduced glutathione, cysteine, and lipoamide also had a 
stimulatory effect on the T4 to T3 converting activity. 
A number of different agents were tested for possible effects on 
the 5'-deiodinase activity of Fraction III (Table 5). The deiodinase ha~ 
no apparent requirement for the presence of metal cofactors or the pre-
sence of other cations or anions. EDTA at a 1.0 mmol/L concentration did 
not significantly effect deiodinase activity. Several salts including: 
potassium chloride, lithium chloride, sodium iodide, magnesium sulfate, 
zinc acetate, mercury chloride and lead nitrate had an inhibitory effect 
on deiodinase activity. Of these compounds, z1nc acetate was the most 
potent inhibitor. Mercury chloride and lead nitrate were not potent in-
hibitors of the 5'-deiodinase in this study due to the presence of 20 
mmol/L dithiothreitol, however, when crude rat liver homogenates were 
assayed in the absence of dithiothreitol, the addition of 0.2 mmol/L lead 
nitrate to the enzyme assay mixture completely inhibited the deiodinase 
activity. This inhibition could be overcome ~n a competitive manner with 
the addition of dithiothreitol. The conversion of T4 to T3 was also 
103 
Figure 19. Effect of various sulfhydryl reagents on iodonthronine 
5'-deiodinase activity. 
Fraction III was used as the source of the 5'-deiodinase act1v1ty. 
Assays were done under standard conditions (19.3 ~mol/L T4) except for 
the variation in cofactor and cofactor concentration. o----o, dithio-
threitol (DTT); • • , Lipcamide; !::r--6., beta mercaptoethanol (BME); 
~ ~. reduced glutathione (GSH); o---o, cysteine (Cys). 
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Table 5 
Effect of Various Agents on Fraction III 
EDTA 
NaCL 
KCL 
LiCL 
TEST 
AGENT 
MnCL2 
Zn(C2H302)2 
Nal 
human serum 
bovine serum albumin 
5'-Deiodinase Activity 
CONCENTRATION 
1. 0 mmol/L 
100.0 mmol/L 
10.0 mmol/L 
20.0 mmol/L 
1. 0 mmo1/L 
5.0 mmol/L 
5.0 mmo1/L 
1. 0 mmo1/L 
1.0 mmo1/L 
0.1 mmo1/L 
1. 0 mmo1/L 
0.1 mmo1/L 
0.1 mmo1/L 
0.8 mmo1/L 
5.0 mmo1/L 
10.0 mmo1/L 
1. 0 mmol/L 
5.0 mmol/L 
5.0 mmol/L 
15 mg protein/ml 
15 mg protein/ml 
105 
% OF CONTROL* 
ACfiVITY 
96 ± 8 
104 ± 9 
96 ± 5 
82 ± 7 
92 ± 6 
78 ± 5 
106 ± 9 
102 ± 10 
96 ± 9 
21 ± 4 
4 ± 2 
96 ± 9 
85 ± 7 
98 ± 9 
94 ± 8 
82 ± 7 
88 ± 7 
48 ± 8 
99 ± 10 
8 ± 2 
38 ± 4 
* mean ± standard deviation for 5 determinations; standard assay 
conditions 
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inhibited by charcoal stripped serum and to a lesser extent, by bovine 
serum albumin. The activity of the 5'-qeiodinase was not significantly 
activated by any of the compounds tested. It was noted, however, that 
ferric chloride enhanced the nonenzymatic, spontaneous deiodination of T4 
to T3. Sodium azide was found to have no effect on T3 formation. 
The T4 to T3 converting activity of Fraction III iodothyronine 5'-
deiodinase was unaffected by large doses of dexamethasone and methima-
zole, however, reverse T3 (rT3), propylthiouracil, propranolol, sodium 
salicylate, iodipamide (Cholografin), and to a lesser extent, sodium dia-
trizoate (Hypaque) inhibited 5'-deiodinase activity in a dose-dependent 
manner (Figure 20). The most potent of these inhibitors was rT3. Kine-
tic studies indicated that rT3 was an apparent non-competit~ve inhibitor 
. 
of the 5'-deiodinase with respeot to both T4 and the essential cofactor, 
dithiothreitol (DTT) (K1 = 0.270 and 0.099 ~mol/L, respectively, Figure 
21). Propylthiouracil was an apparent uncompetitive inhibitor with re-
spect to T4 and an apparent competitive inhibitor with respect to DTT (K1 
= 2.62 and 1.16 ~mol/L, respectively, Figure 22). Sodium salicylate, 
Cholografin, and propranolol were apparent competitive inhibitors of the 
5'-deiodinase with respect to both T4 (K1 = 75 ~mol/1, 19.2 ~mol/1 and 
0.98 mmol/1, respectively) and DTT (K1 = 143 ~mol/L, 10.4 ~mol/1, and 
2.20 mmol/1, respectively, Figures 23-25). 
Determination of Kinetic Parameters and Possible Mechanism of Action 
Double reciprocal plots of the Lineweaver-Burke type derived from 
kinetic data for the Fraction III 5'-deiodinase generated parallel lines 
when velocity versus T4 substrate concentration was plotted for 4 
107 
Figure 20. Comparison of the effect of various inhibitors and related 
compounds on iodothyronine 5'-deiodinase activity. 
Fraction III was incubated under standard enzyme assay conditions 
with the test agents as indicated. • •, reve~se T3; o----o , 
propylthioutacil (PTU); • • , iodipamide (cholografin); o----a, 
sodium salicyt'ate; ~, propranolol; ... A, sodium diatrizoate 
(hypaque); --------- , dexamethasone; -------------------- , methimazole (Tapazole). An 
arbitrary value of 100 was assigned to the amount of T3 produced in the 
control tubes containing no inhibitor, and that produced in the presence 
of test agent was expressed as a percentage of control values. Each 
point is an average of duplicate determinations. 
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Figure 21. Apparent non-competitive inhibition by rT3 with respect to T4 
and apparent non-competitive inhibition by rT3 with respect to dithio-
threitol of T4 to T3 conversion by the Fraction III 5'-deiodinase. 
Varying quantities of T4 at a constant 20 mmo1/L dithiothreitol 
(A), or varying quantities of dithiothreitol at a constant 19.3 ~mol/L T4 
(B) were incubated with 100 ~L Fraction III (0.01 mg protein) in 0.15 mol 
phosphate buffer (pH 6.5) for 30 minutes at 37 °C in the absence or 
presence of rT3. The amount of T3 generated was quantitated by radio-
immunoassay of an ethanol extract of the incubation .mixture. The T4 to 
T3 converting activity data was plotted in the form of a Lineweaver-Burke 
plot: • •, 0.0 rT3; • •, 0.077 ~mol/L rT3; ----, 0.154 \lmol/L 
rT3; X >c, 0.230 ~mol/L rT3; o---o , 0.307 lJmol/L rT3. Each point 
represents the average of duplicate determinations. The Ki for rT3 was 
calculated to be 0.270 ~mol/L with respect to T4 and 0.099 11M with 
respect to dithiothreitol. -
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Figure 22. Apparent uncompetitive inhibition by propylthiouracil with 
respect to T4 and apparent competitive inhibition by propylthiouracil 
with respect to dithiothreitol of T4 to T3 conversion by the Fraction III 
5'-deiodinase. 
The experimental detail as well as the manner o~ plotting the data 
are described in Figure 21 for: • •, 0.0 propylthiouracil (PTU); 
e---e , 1. 2 J.lmol/1 PTU; ----, 2.4 lJmol/1 PTU; X x , 3. 5 lJmol/1 PTU; 
o---o , 4.7 lJmol/1 PTU. The Ki for PTU was calculated to be 2.62 lJmol/1 
with respect to T4 and 1.16 J.lmol/1 with respect to dithiothreitol. 
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Figure 23. Apparent competitive inhibition by iodipamide (Cholografin) 
with respect to both T4 and dithiothreitol of T4 to T3 conversion by the 
Fraction III 5'-deiodinase. 
The experimental detail as well as the manner of plotting are de-
scribed in Figure 21 for: • •, 0.0 iodipamide; e---e, 4.5 Umol/L 
iodipamide; ----, 9.0 Umol/L iodipamide; X ><, 13.6 Umol/L iodipa-
mide; o----o, 18.1 Umol/L iodipamide. The Ki for iodipamide was calcu-
lated to be 19.2 umol/L with respect to T4, and 10.4 Umol/L with respect 
to dithiothreitol. 
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Figure 24. Apparent competitive inhibition by sodium salicylate with 
respect to both T4 and dithiothreitol of T4 to T3 conversion by the 
Fraction III 5'-deiodinase. 
The experimental detail as well as the manner of plotting are de-
scribed in Figure 21 for: • •, 0.0 sodium salicylate; • •, 125 
j..tillol/L sodium salicylate; ---- , 250 llmol/L sodium salicylate; X X , 
375 llmol/L sodium salicylate; o o, 500 llmol/L sodium salicylate. The 
Ki for sodium salicylate was calculated to be 75 llmol/L with respect to 
T4, and 143 llmol/L with respect to dithiothreitol. 
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Figure 25. Apparent competitive inhibition by pro~ranolol with respect 
to both T4 and dithiothreitol of T4 to T3 conversion by the Fraction III 
5'-deiodinase. 
The experimental detail as well as the manner of plotting are de-
scribed in Figure 21 for: • • , 0 propranolol; • •, .0.42 mmol/1 
propranolol;----~, 0.84 mmol/1 propranolol; X )(, 1.27 mmol/1 pro-
pranolol; 0---0 , 1.69 mmol/1 propranolol. The Ki for propranolol was 
calculated to be 0.98 mmol/1 with respect to T4, and 2.20 mmol/1 with 
respect to dithiothreitol. 
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different concentrations of dithiothreitol (Figure 26). The apparent Km 
for T4 varied from 1.03 ~mol/L T4 at a concentration of 3 mmol/L dithio-
threitol (DTT) to 2.46 ~mol/1 T4 at a concentration of 12 mmol/L DTT. 
The appa~ent maximum velocity (Vmax) was also dependent on DTT concen-
tration and varied from 65.8 pmol T3 min-lmg-1 at a concentration of 3 
mmol/L DTT to 162 pmol T3 min-lmg-1 at a concentration ·of 12 mmol/L 
DTT. 
To determine the true Km for the Fraction III 5'-deiodinase at sub-
strate saturation for T4 and DTT, a double reciprocal plot of apparent Km 
T4 values versus DTT concentration was plotted (Figure 27, A). A line 
drawn through the apparent Km T4 values gave a y-intercept of (1/true Km 
T4) and ax-intercept of (-1/true Km DTT) (Dixon and Webb, 1979a). The 
true Km of T4 was calculated to be 5.0 ~mol/L T4 and the true Km of DTT 
was calculated to be 11.6 mmol/L DTT by this procedure. The true Vmax at 
substrate saturation for T4 and DTT was determined in a similar manner by 
a double reciprocal plot of apparent Vmax versus DTT concentration 
(Figure 27, B) (Dixon and Webb, 1979a). They-intercept of this plot ~n­
dicated that the true Vmax for iodothyronine 5'-deiodinase was 320 pmol 
T3 min-1 mg-1. 
In a comparative study, the kinetic parameters of Fraction A (crude 
homogenate), Fraction D (solubilized 5'-deiodinase), and Fraction III 
(purified 5'-deiodinase) were determined for a constant 20 mmol/L concen-
tration of DTT with varying concentrations of T4. The velocity versus T4 
concentration data were plotted in the form of a double reciprocal plot. 
The apparent Km values for Fractions A, D, and III were determined from 
the x-intercept of the primary plot to be: 4.25, 4.05, and 4.35 ~mol/L 
120 
Figure 26. Lineweaver-Burk plot of data for the production of T3 from 
T4 by the Fraction III 5'-deiodinase at different concentrations of 
dithiothreitol (DTT). 
Varying quantities of T4 were incubated with: o----c , 3 mmol/L 
DTT ; e e , 6 mmo 1 /L DTT ; D---o , 9 mmo 1 /L DTT ; and • • , 12 mmo 1 /L 
DTT, and 100 ~L of Fraction III (0.01 mg protein) in 0.15 M phosphate 
buffer (pH 6.5) for 30 minutes at 37 °C. The amount of T3-generated from 
the deiodination of T4 was quantitated by radioimmunoassay of an ethanol 
extract of the incubation mixture •. For: 3, 6, 9, and 12 mmol/L DTT, the 
apparent Kro values were: 1.03, 1.70, 2.15, and 2.46 ~mol/L T4, respec-
tively and the apparent maximum velocities were: 73, 119, 152, and 182 
pmol T3 min-1 mg-1, respectively. The average slope (Kro/Vmax) of the 4 
parallel lines was 0.0142. 
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Figure 27. Determination of Km and Vmax values from replots of kinetic 
data. 
A. A double reciprical plot of the apparent ~ values for T4 from 
Figure 26 was plotted with respect to dithiothreitol concentration. A 
line drawn through the 4 points had a slope (~ DTT/~ T4) of 2.297. The 
y-intercept (1/Km T4) had a value of 2.0 x lOS M-1, and the x-intercept 
(1/~ DTT) had a value of -0.871. a. A double reciprical plot of the ap-
parent VMax values for the conversion of T4 to T3 from Figure 26 was 
plotted with respect to dithiothreitol concentration. A line drawn 
through the 4 points had a slope (~ DTT/VMax) of 0.0356. The y-
intercept (1/VMax) had a value of 0.00298, and the x-intercept (1/Km DTT) 
had a value of -0.877. From the replots of kinetic data, the true ~ for 
T4, the true Km for DTT, and the true VMax for Fraction III were deter-
min~d to be: 5.0 ~mol/L T4, 11.4 mmol/L DTT, and 336 pmol T3 min-lmg-1 
respectively. 
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T4, respectively and the apparent Vmax values for Fractions A, D, and III 
were determined from the y-axis of the primary plot to be: 0.61, 1.42, 
and 285 pmo1 T3 min-1mg-1, respectively. These values represented co~ 
parative data for conditions approaching substrate saturation. 
The fact that the Lineweaver-Burke plot gave parallel lines sug-
gested that the reaction mechanism of the enzyme was that of a two-step 
transfer or ping-pong type reaction. Two additional studies were done to 
further investigate the possibility of a two-step transfer mechanism. In 
the first study (Figure 28), enzyme kinetics were performed in the pre-
sence of the competitive inhibitor, sodium salicylate. A double recipro-
cal plot of velocity versus T4 concentration was repeated. As observed 
in the absence of an inhibitor, parallel lines were obtained in the plots 
for DTT concentrations of 3, 6, and 12 mmol/L. In the second study (Fig-
ure 29), T4 and DTT concentrations were increased while a constant ratio 
of 2.6 ~mol/L T4 : 1 mmol/L DTT was maintained. At this ratio, the ve-
locity of Fraction III deiodinase increased ~n a linear manner over a 
range of from 1.3 to 32.2 umol/L T4. 
Isotopic Studies of The Deiodination of 125I-T4 and 125I-rT3 
The effect of time and pH on the deiodination of 125I-rT3 by Frac-
tion D was studied as shown in Figure 30. Reverse T3 was rapidly metabo-
lized by the crude enzyme preparation to a 125I-labeled metabolite and 
free iodide (125r) (Figure 30, A). Deiodination of rT3 was nearly co~ 
plete after 30 minutes, however, the rT3 metabolite was further deiodi-
nated with a corresponding increase in free iodide. The deiodination of 
rT3 by Fraction D occured more rapidly at pH 7.5 than at pH 7.0 or 6.5 
125 
Figure 28. Demonstration of parallel lines for the Lineweaver-Burk plot 
when kinetic data for the conversion of T4 to T3 was generated in the 
presence of a competitive inhibitor of T4. 
Experimental detial was as described in Figure 26 with the excep-
tion that sodium salicylate (75 ~mol/L) was added to the incubation mix-
ture. o o , 3 mmol/L DTT; o o , 6 mmol/L DTT; • • , 12 mmol/L 
DTT. The average slope of the 3 parallel lines was 0.0351. 
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Figure 29. Linearity of iodothyronine 5'-deiodinase activity with in-
creasing T4 concentrations at a constant molar ratio of T4 to dithio-
threitol. 
Standard enzyme assay conditions for the incubation of Fraction III 
with T4 were altered by varying the concentration-of both T4 and dithio-
threitol. As concentrations of T4 were increased from 1.3 to 32.5 
~mol/L, the concentration of dithiothreitol was increased from 0.5 to 
12.5 mmol/L at a constant ratio of 2.6 ~mol/L T4 to 1.0 mmol/L DTT. Data 
are the mean± standard deviation for quadruplicate determinations. 
150 
-10' 
E 
•c: 
E 
J'() 
1-
0 
E 100 Q. 
-
1-
> 
1-
u 
<( 
w 
(f) 
<( 50 
z 
0 
0 
w 
0 
_I 
l() 
0 
I I C 
0 5 
0 
1 I I I I i I i i I t 1 
10 15 20 
T4 · 10-G M 
5 
-3 
DTT 10 M 
128 
i I i i i I 
25 30 
10 
129 
Figure 30. Effect of time and pH on the deiodination of rT3 by Fraction 
D. 
100 ~L of Fraction D containing 1.2 mg of protein was incubated for 
0.60 min at 37 °C with 400 ~L of a solution containing 15 ~mol/L rT3, 9.2 
~Ci 125r-rT3, 20 mmol/L dithiothreitol, and 100 mmol/L phosphate buffer, 
pH 6.5-7.5. The enzyme assay was terminated by adding 50 ~L of a solu-
tion containing 2 mol NaOH and 5 mol NaCl. Chromatography of 0.4 mL of 
the alkaline extract on Sephadex G-25 sf (See Materials and Methods) re-
sulted in 3 peaks of radioactivity: free iodide cl25r), fractions 8-11; 
125r-rT3 metabolite, fractions 14-20; and rT3 (12Sr-rT3), fractions 22-
30. The results are expressed in terms of percent of total counts (l25r) 
for each peak. A. Fraction D was incubated for: 0, 15, 30, or 60 m1n-
utes in phosphate buffer, pH 7.5. B. Fraction D was incubated for 30 
minutes in phosphate buffer, pH 6.5, 7.0, or 7.5. 
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(Figure 30, B). 
The rate of deiodination of 125I-rT3 with time (Figure 31) and of 
125I-T4 with time (Figure 32) was determined for Fraction D, Fraction III 
and for a mixture of Fraction D and Fraction III. The results after 30 
minutes and 60 minutes for the deiodination of rT3 and T4, respectively 
are presented in Table 6. 
During a 30 minute incubation at pH 7.5, Fraction III deiodinated 
approximately 4 %of the rT3 substrate (Figure 31, A). Fraction D deio-
dinated approximately 72 % of the rT3 substrate in the same time period 
(Figure 31, B). During a 60 minute incubation at pH 6.5, Fraction III 
and Fraction D deiodinated approximately 8% (Figure 32,·A) and 4% (Fig-
ure 32, B) of the T4 substrate, respectively. Therefore, despite the 2-
fold greater activity of Fraction III in the deiodination of T4, Fraction 
III was 18-fold less active than Fraction D in the deiodination of rT3. 
When the enzyme assay was run with a mixture containing equal por-
tions of Fraction III and Fraction D, the rate of deiodination of rT3 was 
equal to approximately one half that of Fraction D alone (Figure 39, C). 
When the mixture of Fraction D and Fraction III was assayed for the de-
iodination of T4, the rate was approximately 1/3 greater than that of 
Fraction D alone (Figure 32, C). 
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Figure 31. Comparison of iodothyronine 5'-deiodinase act1v1ty in Frac-
tion III, Fraction Di and a mixture of Fraction D plus Fraction III for 
the deiodination of 25I-rT3. 
Experimental details were as described in Figure 30. A. 100 ~L 
Fraction III containing 10 ~g protein was incubated for 0, 15, 30 and 60 
minutes in phosphate buffer, pH 7.5. B. 100 ~L Fraction D conta1n1ng 1.2 
mg protein was incubated for 0, 15, 30 and 60 minutes in phosphate buf-
fer, pH 7.5. C. A mixture of SO ~L Fraction D and 50 ~L Fraction III was 
incubated for 0, 15, 30, and 60 minutes in phosphate buffer, pH 7.5. The 
amount of radioactivity in each of 3 peaks following Sephadex G-25 sf 
chromatography was expressed as a percentage of total counts: • • , 
125I-rT3; o o, free 12SI; o o, 12SI-labeled rT3 metabolite. 
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Figure 32. Comparison of iodothyronine 5'-deiodinase act1v1ty in Frac-
tion III, Fraction D, and a mixture of Fraction D plus Fraction III for 
the conversion of T4 to T3. 
100 ~L samples containing: A. Fraction III (10 ~g protein) B. 
Fraction D (1.2 mg protein) or C. 50:50 mixture of Fraction D plus Frac-
tion III were incubated for: 0, 30 and 60 minute time intervals at 37 °C 
with 400 ~L of a solution.contianing 15 ~mol/L T4, 57.2 ~Ci 125I-T4, 20 
mmol/L dithiothreitol and 100 mmol/L phosphate buffer, pH 6.5. The en-
zyme assay was terminated by adding SO ~L of a solution containing 2 
mol/L NaOH and 5 mol/L NaCl. Chromatography of 0.4 mL of the alkaline 
extract on Sephadex G-25 sf (See Materials and Methods) resulted in 3 
peaks of radioactivity: o----a, free iodide (12SI), fractions 8-11; 
o o, l25I-T3, fractions 14-20; and A :A, 12SI-T4, fractions 22-30. 
The amount of radioactiv-ity in each peak was expressed as a percentage 
of total count. 
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Table 6 
Sum1nary of Results (Figures 31 and 32) For the Deiodination of 125I-rT3 
and 125I-T4 BY Fraction D and Fraction III. 
DEIODINATION OF 125I-rT3 DEIODINATION OF 125r-T4 
PERCENT OF TOTAL COUNTS PERCENT OF TOTAL COUNTS 
LABEL 
0 min 30 min ~% 
125r-rT3 94.0 90.0 - 4.0 
l25I-rT3 metabolite 2. l 3.8 + 1. 7 
Free l25I 3.9 6.0 + 2.1 
125r-rT3 94.2 21.8 -72.4 
125r-rT3 metabolite 3.6 40.0 ·+36.4 
Free l25r 2.2 38.2 +36.2 
l25r-rT3 94.0 61.5 -32.5 
125I-rT3 metabolite 3.9 20.3 +16.4 
Free l25I 2.0 18.0 +16.0 
LABEL 
0 min 
125I-T4 86.9 
l25r-T3 6.1 
Free l25r 6.9 
125r-T4 86.6 
125r-T3 6.1 
Free l25I 7.2 
125I-T4 86.3 
l25I-T3 6.3 
Free l25I 7.2 
60 min 
78.8 
9.4 
11.6 
82.6 
6. l 
9.8 
81.0 
8.4 
10.4 
~% 
-8.1 
+3.3 
+4. 7 
-4.0 
+1.3 
+2.6 
-5.3 
+2.1 
+3.2 
...... 
w 
0\ 
CHAPTER IV 
DISCUSSION 
The enzyme catalyzed conversion of T4 to T3 has been demonstrated 
in a number of mammalian tissues (Chopra, 1977a; Cheron ~~' 1980; 
Ishii~~' 1981), and has been implicated as the major source of serum 
T3 in man (Braverman et ~., 1970; Chopra, 1978). The conversion of T4 
to T3 involves the removal of a single iodine atom from the C5', position 
of the outer iodothyronine rLng and, therefore, the converting enzyme 
belongs to a class of enzymes called iodothyronine 5'-deiodinases. Other 
deiodinases which remove an iodine from the inner iodothyronine ring 
belong to a second, distinct class of enzymes, the iodothyronine 5-
deiodinases (Cavalieri~~., 1977; Kaplan and Utiger, 1978; Gavin et 
~·, 1980). The present study has delt exclusively with the 5'-
deiodinase whose substrates include thyronines iodinated in the 3'-
and/or 5 1 -positions, and more specifically, with the isolation and char-
acterization of the rat liver 5'-deiodinase that converts T4 to T3. 
After a conventional subcellular fractionation of rat liv~r homo-
genates, the T4 5'-deiodinase was found to be associated with cellular 
membranes rather than cytosolic proteins, and Ln line with previous stu-
dies using both rat liver and kidney homogenates (Visser~~·· 1976b; 
Takaishi ~~·, 1979; Maciel~~·, 1979), the greatest yield of thy-
roxine 5'-deiodinase activity was obtained in the crude microsomal prepa-
ration. The crude microsomal fraction, however, contained an average of 
no more than 50 % of the total activity, and an increase in specific 
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activity of no more than 4-fold. The majority of the remaining activity 
was located in the crude nuclear fraction. Upon further subfractionation 
of the crude microsomal and nuclear fractions, it was discovered that in 
addition to the microsomes, the plasma membrane was also an important 
source of rat liver 5'-deiodinase activity. Therefore, rather than using 
a microsomal preparation as used in previous studies (Takashi ~~., 
1979; Leonard and Rosenberg, 1980a; Tseng and Latham, 1981), or a plasma 
membrane preparation, a cellular membrane preparation containing both 
microsomal and plasma membranes was chosen as the starting material for 
solubilization and purification of the 5'-deiodinase. This decision was 
made due to the fact that a substantial purification of the enzyme was 
not achieved by subcellular fractionation. 
The solubilization procedure used in this study was effective in 
selectively extracting thyroxine 5'-deiodinase activity from the crude 
rat liver membrane preparation. The yield of solubilized 5'-deiodinase 
activity (-60 %) following extraction with Nonidet P-40 was comparable to 
that reported previously (60-70 %) for extraction with deoxycholate (Leo-
nard and Rosenberg, 1980a), and the 0.05 -0.7% Nonidet P-40 extract pro-
vided a 1.4-fold purification of the crude membrane preparation. Nonidet 
P-40 rather than deoxycholate, as used in previous studies (Takaishi ~ 
~., 1979; Leonard and Rosenberg, 1980a; 1980b; Tseng and Latham, 1981), 
was chosen for solubilization of the rat liver 5'-deiodinase because the 
catalytic activity of the enzyme was much less inhibited in the presence 
of Nonidet P-40 than in the presence of deoxycholate (See Figure 18). As 
a result, enzyme assays could be carried out 1n the presence of low 
levels of Nonidet P-40 without the necessity of detergent removal. An 
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additional advantage of the use of the nonionic detergent was that losses 
of enzyme activity during a single pass through a Sepharose 6B gel infil-
tration column were in the range of 35-45 % when Nonidet P-40 was used as 
the dispersing agent compared to losses in activity of greater than 90 % 
when deoxycholate was used as the dispersing agent (Leonard and Rosen-
berg, 1980a). 
The extracted rat liver 5'-deiodinase remained in the supernatant 
solution after high speed centrifugation (78,000 x £' 60 min) and, there-
fore, appeared to be soluble. The enzyme precipitated following acidifi-
cation (pH 5.8 -6.0), however, in a manner characteristic of detergent 
"solubilized" lipoprotein complexes (Penefsky and Tzagoloff, 1971). The 
lipoprotein nature of the Nonidet P-40 solubilized 5'-deiodinase was fur-
ther supported by demonstrating that the enzyme was poorly soluble in 
aqueous buffer. Thus, while Sepharose 6B-CL chromatography in the pre-
sence of 0.1% Nonidet P-40 allowed elution of the 5'-deiodinase after the 
void volume, chromatography in the absence of surfactant resulted in the 
formation of macromolecular complexes of the enzyme which eluted in the 
void volume. A similar phenomenon was also reported for the thyroxine 
5'-deiodinase extracted from rat liver microsomal preparations with deox-
ycholate (Leonard and Rosenberg, 1980a). In addition, evidence of the 
intrinsic nature of the 5'-deiodinase, as demonstrated by the fact that 
extraction required extensive membrane disassembly (Figures 6 and 7), in-
dicated that the enzyme had a strong association with membrane lipids 
(Takaishi ~ ~., 1979). Therefore, rather than existing in true solu-
tion, the Nonidet P-40 extracted 5'-deiodinase was apparently suspended 
in detergent micelles containing the 5'-deiodinase and associated mem-
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brane phospholipids. 
Th~ presence of residual amounts of membrane phospholipid has been 
reported to be a requirement of enzymatic activity for the rat liver 5'-
deiodinase (Leonard and Rosenberg, 1980a). Therefore, delipidation which 
is known to occur in the presence of surfactants during membrane solubi-
lization (Tzagoloff and Penefsky, 1971) and gel filtration chroma-
tography (Fry and Green, 1980; Penefsky and Tzagoloff, 1971) could ex-
plain, in part, losses of activity whch occured in the present study. 
Accordingly, optimum conditions for solubilization and purification of 
the 5'-deiodinase were empirically determined to maximize stability of 
the extracted enzyme complex. In the present study, the use of Nonidet 
P-40 allowed for the first time the solubilization of an active form of 
the 5'-deiodinase complex from rat liver membranes which was reasonably 
stable in low concentrations of the dispersing detergent. 
Prelimina~y attempts to purify the 5'-deiodinase demonstrated the 
usefulness of DEAE cellulose, hydroxylapatite, and Sepharose 6B-CL 
chroma-tography ateps in the purification of the Nonidet P-40 solubilized 
enzyme. High yields and increases in relative specific activity follow-
ing each step supported the efficacy of the multistep procedure. The 
first step in the purification scheme involved reverse anion exchange 
chromatography on DEAE cellulose. The majority of the 5'-deiodinase did 
not adsorb to the column matrix and was, therefore, separated from the 
proteins that did adsorb. In addition, elution of the 5'-deiodinase from 
the cellulose column was retarded, allowing separation of the enzyme from 
the bulk of the non-adsorbed protein also. As a result, the bulk of the 
cellulose step allowed purification of the 5'-deiodinase through both ion 
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exchange interactions and apparent hydrophobic interactions in a single 
step. The second step involved adsorption chromatography on hydroxylapa-
tite. The third step, gel filtration chromatography on Sepharose 6B-CL, 
permitted the removal of high and low molecular weight contaminants. The 
enzyme was remarkably stable through all stages of purification. Sur-
prisingly, the first two steps in the purification scheme resulted in a 
mild activation of the enzyme. This behavior was very similar to the en-
hancement of activity following solubilization with deoxycholate 
(Takaishi ~~., 1979) and may have been associated with the removal of 
tissue factors which mask enzymatic activity in crude homogenate prepara-
tions (Leonard and Rosenberg, 1977). 
Purification of the rat liver iodothyronine 5'-deiodinase by the 
method reported here resulted in a 580-fold enrichment in specific activ-
ity and a 24 % recovery. The final product was purified from 100 to 300 
times greater than microsomal preparations previously used for character-
ization of the 5'-deiodinase, which had increases in specific activity of 
from 2- to 6-fold (Visser et. ~., 1976b; Hoffken et. ~·, 1978; auf dem 
Brinke et. ~., 1979). An additional advantage of the purification 
scheme was that the final product was prepared in a soluble, yet active 
form. Therefore, detergent removal was not required prior to performing 
kinetic determinations. All previous kinetic studies have been performed 
on insoluble enzyme preparations of either cellular membranes or DOC-free 
extracts. The purification procedure used in this study has for the 
first time allowed kinetic assays to be performed with a soluble enzyme 
preparation. 
Upon gel filtration chromatography of the purified 5'-deiodinase, a 
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single sharp peak of activity was observed with an apparent molecular 
weight of approximately 250,000 and an apparent Stokes' radius of approx-
imately 5.8 nm. There was no detectable activity at the void volume and 
there were no other minor peaks of activity. Based on results with 
deoxycholate solubilized enzyme preparations, where two enzyme forms of 
molecular weight 85,000-95,000 and 200,000 were observed (Leonard and 
Rosenberg, 1980a; Tseng and Latham, 1981), the Nonidet P-40 solubilized 
5'-deiodinase complex may have been a dimer. The presence of a monomeric 
subunit of the 5'-deiodinase may, therefore, have been the cause of the 
shoulder in the low molecular weight range during chromatography of Frac-
tion II on Sepharose 6B-CL (Figure 11). The difference in the molecular 
weight estimates of 250,000 in the present study and 200,000 in the pre-
vious study was expected on the basis that the nonionic detergents, 
Triton X-100 and Nonidet P-40 tend to form larger mixed micelles with 
membrane proteins than do anionic detergents (Helenius and Simons, 
1975). 
Column isoelectric focusing of the purified iodothyronine 5'-
deiodinase resulted in the formation of a single major peak of enzyme 
activity which had a pi of 7.4. The presence of a single peak of activ-
ity indicated that the majority of the Nonidet P-40 solubilized, enzyme 
complex existed in a single e1ectrophorectic form. The formation of 
minor peaks of activity were not consistent in size or location and, 
therefore, were not considered to be evidence of multiple isoenzyme forms 
of the 5'-deiodinase. Approximately 10 % or less of the applied activity 
was recovered due to precipitation of the enzyme despite the presence of 
0.1 % Nonidet P-40. Therefore, isoelectric focusing was not included as 
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a preparatory step in the purification scheme. The procedure would be 
advantageous, however, in cases where a high degree of purity is of para-
mount importance. 
The catalytic activity of the purified iodothyronine 5'-deiodinase 
was studied under a variety of conditions to determine the parameters 
that effect the in vitro conversion of T4 to T3. It was observed that 
factors modulating the 5'-deiodination of T4 included the temperature and 
pH of incubation, that activity was linear with respect to protein con-
centration, and that activity was dependent on the concentration of sub-
strate (T4). These effects demonstrated that the converting activity of 
the Fraction III preparation was enzymatic in nature. 
Fraction III iodothyronine 5'-deiodinase activity had an absolute 
requirement for sulfhydryl group-containing compounds. Unlike crude ho-
mogenates which were active in the absence of exogenous cofactor (Chopra, 
1977b; Balsam and Ingbar, 1979; Harris et. ~., 1979), the catalytic 
activity of the purified enzyme required the presence of a reduced thiol. 
The relative potency of several selected sulfhydryl compounds is shown in 
Figure 19. Dithiothreitol had the greatest stimulatory effect, demon-
strating substratre saturation above a 20 mmol/1 concentration. Beta-
mercaptoethanol, reduced glutathione, cysteine and lipoamide also had 
concentration dependent stimulatory effects. Due to the fact that the 
thiol group was an essential cofacto~, it was considered to have the 
status of a second substrate. 
The T4 to T3 converting activity of the purified 5'-deiodinase de-
monstrated no apparent requirement for the presence of metal cofactors or 
for the presence of other monovalent or divalent ions. In line with 
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results from previous studies (Visser~~., 1976b; Chopra, 1976; Sori-
machi and Robbins, 1979), EDTA had no effect and ca2+, Mg2+, and Mn2+ at 
1 mmol/L concentrations had no effect or only slightly increased the rate 
of deiodination. Ferric ion did not stimulate Fraction III activity, 
however, ferric ion did accelerate the nonenzymatic deiodination of T4 in 
blank tubes containing heat inactivated enzyme. Therefore, it was con-
eluded that the stimulation of T4 to T3 conversion by ferric ion reported 
previously (Chiraseveenuprapund ~~., 1978) may have been the result 
of chemical rather than enzymatic catalysis. In the present study, 0.1 
mmol/L zn2+ inhibited 5'-deiodinase activity, but it is not known whether 
this effect was on the enzyme, on the cofactor, or on the solubility of 
the substrate. 
Mercury and lead had a potent inhibitory effect on the T4 to T3 
converting activity which could be reversed with the addition of dithio-
threitol to the incubation mixture. Due to the catalytic requirement of 
the 5'-deiodinase for a thiol cofactor, this effect may have been due to 
a sulfhydryl-blocking effect on the cofactor (Chopra, 1977a). On the 
other hand, it has also been demonstrated that the enzyme itself has an 
essential sulfhydryl group in its active site (Leonard and Rosenberg, 
1980b). Therefore, the inhibition by heavy metals may also have been due 
in part to a direct inhibition of the enzyme. In either case, the inhi-
bition by mercury and lead was competitive in nature and could be over-
come with the addition of dithiothreitol. 
Inhibition of 5'-deiodinase activity by bovine serum albumin and by 
human serum proteins was observed ~n the present study as well as in a 
previous report (Chiraseveenuprapund et. ~·, 1978). The nature of the 
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inhibition was presumed to be due to the thyroxine binding capacity of 
albumin and thyroid binding globulin which are reported to have associa-
tion constants for thyroxine of 1 x 106 mol-l and 3 x 1olO mol-l, respec-
tively (Nicoloff, 1978). In a likewise manner, rat liver and kidney mem-
brane proteins which have high affinities for T4 (Oppenheimer and Surks, 
1975; Sterling~~., 1977; Rall, 1978) have the potential for inter-
fering with the kinetics of 5'-deiodinase activity by lowering the ef-
fective substrate concentration. Therefore, extensive purification of 
the enzyme activity is highly desirable prior to the determination of 
kinetic parameters. 
In addition to the a~ents mentioned above, the present study in-
eluded an examination of the effects of several compounds wh~ch have been 
reported to inhibit either the thyroidal or peripheral metabolism of thy-
roxine. Of the compounds tested, the most potent inhibitor of Fraction 
III activity was reverse T3. Preliminary kinetic data from two previous 
studies utilizing the crude rat liver homogenate preparations as the 
source of 5'-deiodinase activity indicated that rT3 inhibited the 5'-
deiodinase in an apparent competitive manner with respect to T4 (Chopra, 
1977a; Kaplan and Utiger, 1978) and, therefore, that T4 and rT3 compete 
for the same binding site of the 5'-deiodinase. On the other hand, my 
results with the purified Fraction III enzyme suggest non-competitive 
inhibition by rT3. Non-competitive inhibition suggests that rT3 binds to 
a site on the enzyme other than that for the binding of T4 and dithio-
threitol and, therefore, that the purified thyroxine 5'-deiodinase has a 
minimum of two binding sites for iodothyronines. A similar conclusion 
II 
was reached by Hufner et. ~., (1977) in a report in which kinetic stu-
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dies were performed with rat liver homogenates. 
Inhibition of thyroxine 5'-deiodinase activity by propylthiouracil 
(PTU) was observed to occur in the present study and in a previous study 
(Chopra, 1977a) in an apparent uncompetitive manner. This type of inhi-
bition is characteristic of an inhibitor that binds reversibly to an 
enzyme-substrate complex but not to the free enzyme. With regard to the 
5'-deiodinase, a likely candidate for an enzyme-substrate complex that 
would have a high affinity for PTU is the enzyme-sulfenyl iodide inter-
mediate which has been postulated to result from the deiodination of T4 
(Visser et. ~·, 1979b; Leonard and Rosenberg, 1980b). This hypothesis 
is supported by the work of Cunningham, who has shown that PTU readily 
forms mixed disulfides with protein-sulphenyl iodide groups (Cunningham, 
1964). It has also been shown that uracil without the sulfur component 
is devoid of inhibitory activity (Visser et. ~., 1979b) and, therefore, 
that the affinity of PTU for the enzyme was derived solely from the pre-
sence of the thiol group. Additionally, it was observed that PTU inhi-
bited the 5'-deiodinase in a competitive manner with respect to dithio-
threitol. The competitive nature of the inhibition by PTU could be 
explained as a competition between dithiothreitol and PTU for the postu-
lated sulphenyl iodide group. The data obtained in the present study, 
therefore, indicate that the 5'-deiodination of T4 was very similar to 
the 5'-deiodination of rT3 which also was inhibited by PTU in an uncom-
petitive manner with respect to rT3 and in a competitive manner with 
respect to dithiothreitol (Visser et. ~., 1979a). 
Other compounds were shown to inhibit the Fraction III 5'-
deiodinase in a competitive manner. Iodipamide (Cholografin), an iodi-
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enzyme competitively with respect to both T4 and dithiothreitol. Other 
iodinated x-ray contrast agents such as iopidate (Oragrafin), iopanoic 
acid (Telepaque) and sodium tyropanoate (Bilopaque) have also been shown 
to be potent dose dependent inhibitors of the T4 to T3 converting enzyme 
in rat liver (Kaplan and Utiger, 1978; Chopra~~., 1978) and pitui-
tary homogenates (Larsen~~., 1979), and Oragrafin, like Cholografin, 
has been shown to be a competitive inhibitor with respect to T4 (Chopra 
et. ~., 1978). The x-ray contrast agents were structurally related to 
the idothyronines in that they all contained a saturated phenol ring con-
taining iodine substituant. Sodium diatrizoate (Hypaque), on the other 
hand, did not have an inhibitory effect on the purified 5'-deiodinase de-
spite a similarity in structure to the above mentioned x-ray contrast 
agents. This may have been due to charge repulsion or to steric hin-
drance. 
Propranolol, a beta-adrenergic blocking agent commonly used 1n the 
treatment of hyperthyroid patients, also demonstrated competitive inhi-
bition in a dose dependent manner with respect to both T4 and dithio-
threitol. Binding affinity was poor, however, and a 2 mmol/L concen-
tration of propranolol was required to inhibit activity by 50 %. Pre-
vious studies (Lumholtz et. ~·, 1979; van Noordan et. ~., 1979) have 
also demonstrated the in vitro inhibition of 5'-deiodinase activity by 
propranolol, but failed to demonstrate a concentration dependent inhibi-
tory effect in their crude enzyme preparations. Two other drugs used to 
treat hyperthyroid patients: dexamethasone, which has been shown to 
decrease the in vivo conversion of T4 to T3, (Croxson et. ~·, 1977; 
Chopra et. ~., 1975), and methimazole, an antithyroid agent, (Chira-
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seveenuprapund ~~., 1978) were found not to have an inhibitory effect 
on the purified 5'-deiodinase. These results were also observed in some 
other recent studies which employed rat liver (Chopra, 1977a) and kidney 
homogenates (Chiraseveenprapund ~~., 1978). 
Sodium salicylate and anilino-naphthalenesulfonic acid (ANS) have 
been known for some time to displace T4 and T3 from circulating thyroxine 
binding proteins. More recently, it has been shown that salicylate and 
ANS also inhibit the T4 to T3 converting activity of the 5'-deiddinase 
(Chiraseveenuprapund ~~., 1978; Chopra~~., 1980). Therefore, 
while the possibility exists that salicylate and ANS may compete with T4 
for binding sites of the 5'-deiodinas~ as well as for binding sites of 
the transport proteins, these observations have also been interpreted to 
indicate that a protein-bound form of T4 could be the normal substrate 
for the T4 to T3 converting enzyme (Chiraseveenuprapund ~~., 1978). 
The protein bound to T4 in this case would be an intracellular protein, 
not thyroid binding globulin (TBG). In the present study, the fact that 
removal of the soluble proteins (Fraction B) from the membrane prepara-
tion (Fraction C) did not result in the loss of enzymatic activity and 
the fact that the presence of BSA and human serum strongly inhibited the 
catalytic rate strongly suggest that the free form of thyroxine was the 
normal substrate for the 5'-deiodinase. 
Michaelis-Menten kinetics were observed in the present study for 
the conversion of T4 to T3 by the Fraction III 5'-deiodinase when enzyme 
assays were carried out in the presence of 0.2 % Nonidet P-40. Thus, 
when kinetic data was plotted in a double reciprical manner for velocity 
versus substrate concentration, the data was linear for the range of: 
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1 to 20 ~mol/L T4 and 1 to 20 mmol/L dithiothreitol. Similar results 
were obse~ved for kinetic assays carried out with crude rat liver prep-
• ( II arat1ons Hufner et. ~., 1977; Chopra, 1977a; Kaplan and Utiger, 1978; 
Visser, 1979) and crude rat kidney preparations (Leonard and Rosenberg, 
1978). The apparent Km (4.35 ~mol/L T4) determined for the purified 
Fraction III 5'-deiodinase was in accordance with values previously 
reported for crude preparations of the T4 5'-deiodinase (0.8 to 7.7 
II ~mol/L T4) (Hufner ~~·, 1977; Chopra, 1977a; Kaplan and Utiger, 
1978; Leonard and Rosenberg, 1978; auf dem Brinke et. ~., 1979; Visser 
~~·, 1979a) and was approximately equal to the apparent Km of the 
Fraction A 5'-deiodinase (4.25 ~mol/L T4). The close relationship of the 
Km of the purified enzyme to ~hat of the crude membrane bound preparation 
. . 
demonstrated that the structural integrity of the detergent solubilized 
enzyme had not been greatly altered during solubilization and purifi-
cation. 
The magnitude of T3 generation from T4 by the Fraction III iodothy-
ronine 5'-deiodinase observed in the present study was approximately 300 
pmol T3 min-1mg-1. This result reflects the increased purity of the 
Fraction III preparation as compared to the rat liver microsomal prepara-
tion (Fraction P) and the crude rat liver homogenate (Fraction A) which 
had velocities of 1.81 pmol T3 min-lmg-1 and 0.53 pmol T3 min-1mg-l, 
respectively. These results approximated previously reported velocities 
of: 0.04 pmol T3 min-lmg-1 (H~fner ~~·· 1977), 0.13 pmol T3 min-
lmg-1 (Kaplan and Utiger, 1978) and 0.07 pmol T3 min-lmg-1 (Chopra~ 
~·, 1979) for a rat liver microsomal preparation; and of 1.2 pmol T3 
min-1 mg-1 (Leonard and Rosenberg, 1980b) for a rat kidney microsomal 
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preparation. An earlier report of the velocity for a rat liver micro-
somal preparation of approximately 0.02 pmol T3 min-lmg-1 (Hesch!!~·· 
1975) was low due to absence of added cofactor (thiol compound such as 
mercaptoethanol or dithio-threitol during incubation). Another report of 
a maximum velocity of 63 pmol T3 min-1mg-1 (Visser!!~·· 1979a) for a 
rat liver microsomal preparation appeared to be extremely high when com-
pared to previously reported values and those observed in the present 
study, especially since the reported purification of the microsomal pre-
paration was only 2- to 3-fold greater than the crude rat liver homo-
genate which had a reported Vmax of 2.9 pmol T3 min-lmg-1 (Visser et 
~·' 1976b). 
Among other factors, such as differences in pH, ionic strength, and 
T4 substrate concentrations, a major factor contributing to differences 
in reported Km and Vmax values for the 5'-deiodinase was differences in 
cofactor and cofactor concentration. In the present study, for example, 
an increase in dithiothreitol concentration in the incubation buffer from 
3 to 20 mmol/L DTT resulted in an increase in Km of from 1.03 to 4.35 
umo1/L T4 and an increase in Vmax of from 65.8 to 285 pmol T3 min-
lmg-1 for the Fraction III 5'-deiodinase. Though not as apparent in the 
crude rat liver homogenate (Chopra, 1977b), this phenomenon has also been 
observed for rat liver microsomal preparations (Visser, 1979) and rat 
kidney microsomal preparations (Leonard and Rosenberg, 1978). Despite 
this fact, all previous determinations of kinetic constants for the 5'-
deiodinase have been calculated for less than optimal cofactor concen-
trations. In the present study, replots of the kinetic data (Figure 27) 
generated from apparent Km and Vmax values obtained at different concen-
trations of dithiothreitol were utilized to determine the true kinetic 
parameters (Dixon and Webb, 1979a). 
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The parallel increase in Km and Vmax with increasing dithiothreitol 
concentration generated a family of parallel lines when double reciprocal 
plots of velocity versus T4 concentration for the 5'-deiodinase were 
plotted with respect to varying concentrations of dithiothreitol (Figure 
26). This type of kinetic behavior is characteristic of that observed 
for two-step transfer reactions (Cleland; 1963), and indicated that the 
conversion of T4 to T3 might occur by a ping-pong type mechanism: 
T4 T3 2SH s-s + HI 
E-SH 
According to the ping-pong reaction mechanism, the reductive deiodination 
of T4 would occur in 2 consecutive steps. In the first step, the C5•-
iodine of the outer ring of T4 would be removed generating the first pro-
duct, T3. In the second step, the oxidized enzyme intermediate (E-SI), 
which was proposed to be a sulphenyl iodide (Visser~~., 1979b; Leo-
nard and Rosenberg, 1980b) would be reduced back to its original active 
form (E-SH) and HI would be released as the second product as 2 equiva-
lents of the thiol group-containing cofactor were oxidized. The occur-
ence of parallel lines in the double reciprocal plot of velocity versus 
substrate concentration for different concentrations of cofactor has also 
been observed for the conversion of T4 to T3 in rat kidney microsomal 
preparations (Leonard and Rosenberg, 1978) and for the conversion of rT3 
to 3,3-'T2 in rat liver microsomal preparations (Visser, 1979b), however, 
the present data provides the first evidence that the conversion of T4 to 
152 
T3 by the rat liver T4 5'-deiodinase occured by the same mechanism. 
The fact that the kinetic data resulted in parallel lines in the 
double reciprocal plot suggests, but does not prove that the 5'-
deiodinase obeyed a true two-step transfer mechanism. Compulsory-order 
equilibrium systems also generate parallel lines in double reciprocal 
plots when the product of the substrate dissociation constant (Kg) for 
substrate A (T4) and the Michaelis-Menten constant (Km) for substrate B 
(DTT) are very small in comparison to the product of the concentrations 
of substrates a and b (KgA•KmB/a•b) (Dixon and Webb, 1979a). One way to 
distinguish between the two systems is to use a competitive inhibitor of 
substrate A. If the lines in the double reciprocal plot appeared paral-
lel because the value of KgA was very low, carrying out the kinetic 
determinations in the presence of a fixed amount of competitive inhibitor 
can be used to increase the apparent KgA and thereby result in a conver-
gence of the plotted lines for varying concentrations of substrate B 
(Dixon and Webb, 1979b). Figure 28 shows the double reciprocal plot for 
the 5'-deiodinase as determined in the presence of 75 ~mol/L sodium 
salicylate which was found in the present study to be a competitive 
inhibitor of the Fraction III 5'-deiodinase with respect to both thy-
roxine and dithiothreitol. The generation of parallel lines in Figure 
28, therefore, gave added support to the hypothesis of ping-pong kine-
tics. 
In the present study, substrate inhibition by T4 was observed at 
low detergent concentrations when the concentration of T4 was increased 
above 20 ~mol/L T4 ~n the presence of 20 mmol/L DTT (Figure 25), and when 
DTT concentrations were increased above 20 mmol/L DTT in the presence of 
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ferent isoenzymes of the T4 5'-deiodinase were present in the rat liver 
microsomal preparation. In the present study, no evidence was observed 
for the presence of multiple isoenzymes of the T4 to T3 converting enzyme 
during the determination of molecular weight and isoelectric point, or 
during the determination of catalytic parameters for the purified rat 
liver 5'-deiodinase. 
The fact that crude rat liver and kidney preparations are active in 
the 5'-deiodination of both T4 and rT3, and the observation that the con-
version of T4 to T3 and the conversion of rT3 to 3,3' T2 are similar in 
many respects has led to an ongoing debate over whether or not the same 
enzyme is responsible for the reductive deiodination of the 2 idothyro-
nines. Evidence supportive of a one enzyme hypothesis is based on the 
observations that the subcellular distribution of both activities are 
similar (Maciel et ~., 1979; Leonard and Rosenberg, 1980a), that both 
activities are affected in a similar manner by a variety of inhibitors 
including propylthiouracil, iodoacetic acid and ipodate (Oragrafin) 
(Chopra, 1978; Eisenstein~~., 1980), and that rT3 and T4 inhibit the 
deiodination of each other in a dose dependent manner (Kaplan and Utiger, 
1978; Visser~~·, 1979a). Evidence supportive of the existence of 
separate enzymes for the deiodination of T4 and rT3 is based primarily on 
temporal differences in the early abrupt rise in serum T3 concentrations 
and the delayed decline in serum rT3 concentrations which occur postna-
tally in the neonate (Chopra~~., 1975a). These differences have been 
interpreted to indicate that the conversion of T4 to T3 and the clearance 
of rT3 are carried out by different pathways (Chopra, 1978; Maciel et 
~., 1979). Additionally, differences in optimum pH observed for the 
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conversion of T4 to T3 (pH 6.5) and for the conversion of rT3 to 3,3'-T2 
(pH 8.0) (Visser~!!·, 1979a) are also suggestive of the existence of 
separate enzymes. In the present study, enzyme assays utilizing 125I-
labeled substrates demonstrated that the crude solubilized 5'-deiodinase 
(Fraction D) was active in the deiodination of both T4 and rT3. There-
fore, both activities were present in the membrane bound fraction of the 
rat liver homogenate and both activities solubilized in an active form in 
the presence of Nonidet P-40. The purified 5 1 -deiodinase preparation 
(Fraction III), on the other hand, demonstrated a minimal capacity to 
deiodinate rT3. On an equal volume basis, Fraction III was approximately 
20 times less active than the crude preparation in the deiodination of 
rT3 despite the fact that it was at least twice as active as Fraction D 
in the conversion of T4 to T3. Therefore, the rT3 deiodinase activity of 
Fraction D was either removed or inactivated during purification. The 
fact that the addition of Fraction D to Fraction III did not result in 
reactivation of the Fraction III rT3 deiodinase activity suggested that a 
loss of cofactor during purification was not responsible for the low rT3 
deiodinase activity of the Fraction III preparation. The failure of the 
rT3 5'-deiodinase activity to co-purify with the T4 5'-deiodinase plus 
the fact that the deiodination of T4 and rT3 occured optimally at pH 6.5 
and pH 7.5 or higher, respectively is, therefore, strongly suggestive 
that different enzymes might be involved in the deiodination of T4 and 
rT3. 
SUMMARY 
Recent reports of reciprocal changes in serum 3,3,5'-triiodo-
thyronine (T3) and 3,3' ,5 1 -triiodothyronine (rT3) levels during starva-
tion, stress and febrile illness have stimulated interest in what appears 
to be a physiologically regulated, control mechanism whereby the body can 
fine~ the biological effects of the thyroid hormones. A previously 
unpurified, membrane-bound iodothyronine 5'-deiodinase, which activates 
thyroxine (T4) by converting it to the more physiologically active hor-
mone T3, is thought to be primarily responsible for control of this path-
way. 
The purpose of this study was to solubilize and partially purify 
the iodothyronine 5'-deiodinase from rat liver membranes and to charac-
terize the purified enzyme in terms of substrate specificity, catalytic 
parameters, molecular weight, and isoelectric point. The mechanism of 
action of the enzyme was also examined. 
Results indicated that 0.7% Nonidet P-40 was effective in solubil-
izing up to 60 % of the 5'-deiodinase activity from rat liver membranes. 
After solubilization, the 5'-deiodinase was purified 580-fold. The puri-
fied enzyme eluted in a single peak during analytical gel filtration, and 
a single peak of 5'-deiodinase activity was also observed during isoelec-
tric focusing. The active complex had an apparent molecular weight of 
250,000 and an apparent isoelectric point of 7.4. 
Kinetic assays demonstrated that the purified 5'-deiodinase was 
optimally active at 37 °C and pH 6.5, and that there was an absolute re-
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quirement for the presence of a thiol group-containing cofactor. The 
most potent cofactor, dithiothreitol (DDT), was used in this work. The 
Km value for T4 was dependent on the concentration of cofactor and paral-
lel lines in the Lineweaver-Burk plot were generated when kinetic data 
for the conversion of T4 to T3 were plotted for varying concentrations of 
DTT. This data as well as other observed catalytic properties of the 
purified enzyme were consistent with the hypothesis of a ping-pong mecha-
nism of action for the rat liver T4 5'-deoidinase. At saturating sub-
strate and cofactor conditions, the Km values for T4 and DDT were deter-
mined to be 5.0 ~mol/L and 11.4 mmol/L, respectively, and the Vmax for 
the purified enzyme was 320 pmol T3 min-lmg protein-1. Reverse T3 was an 
apparent non-competitive inhibitor with respect to both T4 and DTT. 
Cholografin, sodium salicylate and propranolol were dose dependent, comr 
petitive inhibitors with respect to both T4 and DTT. Propylthiouracil 
inhibited the reaction un-competitively with respect to T4 and competi-
tively with respect to DTT. 
Despite a high binding affinity for rT3 (K1 = 9.9 x lo-8 mol/L), 
the purified 5'-deiodinase did not actively deiodinate rT3. 
These data suggest the existence of a single specific thryoxine 5'-
deiodinase in rat liver membranes that catalyzes the conversion of T4 to 
T3, and that can be solubilized and purified in the presence of Nonidet 
P-40 as a dispersing agent. The fact that the purified enzyme did not 
catalyze the 5'-deiodination of rT3 is interesting because it suggests 
the possible existence of a specific reverse T3 5'-deiodinase, and there-
fore, that the peripheral deiodination scheme for the iodothyronines may 
be more complex than orignally anticipated. 
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